{"id":43026,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/agreement-and-plan-of-merger-and-reorganization-visx-inc-and.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"agreement-and-plan-of-merger-and-reorganization-visx-inc-and","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/planning\/agreement-and-plan-of-merger-and-reorganization-visx-inc-and.html","title":{"rendered":"Agreement and Plan of Merger and Reorganization &#8211; VISX Inc. and Medjet Inc."},"content":{"rendered":"<pre>================================================================================\n\n\n                 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION\n\n                                  BY AND AMONG\n\n                               VISX, INCORPORATED,\n\n                             ORION ACQUISITION CORP.\n\n                                       AND\n\n                                   MEDJET INC.\n\n\n                           DATED AS OF AUGUST 17, 2001\n\n\n================================================================================\n\n\n\n   2\n\n                                TABLE OF CONTENTS\n\n<\/pre>\n<table>\n<caption>\n                                                                                               PAGE<br \/>\n                                                                                               &#8212;-<br \/>\n<s>                                                                                            <c><br \/>\nARTICLE I THE MERGER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..2<\/p>\n<p>        1.1    The Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;2<br \/>\n        1.2    Effective Time; Closing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..2<br \/>\n        1.3    Effects of the Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.3<br \/>\n        1.4    Certificate of Incorporation; Bylaws&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.3<br \/>\n        1.5    Directors and Officers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;3<br \/>\n        1.6    Effect on Capital Stock&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..3<br \/>\n        1.7    Dissenting Shares&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..4<br \/>\n        1.8    Surrender of Certificates&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;5<br \/>\n        1.9    No Further Ownership Rights in Company Common Stock&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.6<br \/>\n        1.10   Lost, Stolen or Destroyed Certificates&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..6<br \/>\n        1.11   Taking of Necessary Action; Further Action&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.6<\/p>\n<p>ARTICLE II REPRESENTATIONS AND WARRANTIES OF COMPANY&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;6<\/p>\n<p>        2.1    Organization and Qualification; Subsidiaries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..6<br \/>\n        2.2    Certificate of Incorporation and Bylaws&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.7<br \/>\n        2.3    Capitalization&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..7<br \/>\n        2.4    Authority Relative to this Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.9<br \/>\n        2.5    No Conflict; Required Filings and Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.9<br \/>\n        2.6    Compliance; Permits&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..10<br \/>\n        2.7    SEC Filings; Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;10<br \/>\n        2.8    No Undisclosed Liabilities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.11<br \/>\n        2.9    Absence of Certain Changes or Events&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;11<br \/>\n        2.10   Absence of Litigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;12<br \/>\n        2.11   Employee Benefit Plans&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..12<br \/>\n        2.12   Labor Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..14<br \/>\n        2.13   Proxy Statement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;14<br \/>\n        2.14   Restrictions on Business Activities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.14<br \/>\n        2.15   Title to Property&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.15<br \/>\n        2.16   Taxes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.15<br \/>\n        2.17   Environmental Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;17<br \/>\n        2.18   Brokers&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..17<br \/>\n        2.19   Intellectual Property&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;17<br \/>\n        2.20   Agreements, Contracts and Commitments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..21<br \/>\n        2.21   Insurance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;22<br \/>\n        2.22   Board Approval&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.22<br \/>\n        2.23   Vote Required&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..22<br \/>\n        2.24   State Takeover Statutes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.22<\/p>\n<p>ARTICLE III REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..22<\/p>\n<p>        3.1    Organization and Qualification; Subsidiaries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.23<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                      -i-<br \/>\n   3<br \/>\n                               TABLE OF CONTENTS<br \/>\n                                  (CONTINUED)<\/p>\n<table>\n<caption>\n                                                                                                            PAGE<br \/>\n                                                                                                            &#8212;-<br \/>\n<s>                                                                                                          <c><br \/>\n        3.2    Authority Relative to this Agreement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.23<br \/>\n        3.3    No Conflict; Required Filings and Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.23<br \/>\n        3.4    Ownership of Merger Sub; No Prior Activities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..24<\/p>\n<p>ARTICLE IV CONDUCT PRIOR TO THE EFFECTIVE TIME&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;24<\/p>\n<p>        4.1    Conduct of Business by the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;24<\/p>\n<p>ARTICLE V ADDITIONAL AGREEMENTS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;27<\/p>\n<p>        5.1    Initial Payment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.27<br \/>\n        5.2    Related Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.27<br \/>\n        5.3    Parent Warrant&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..27<br \/>\n        5.4    Proxy Statement&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.28<br \/>\n        5.5    Stockholder Meeting&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;28<br \/>\n        5.6    Confidentiality; Access to Information&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..29<br \/>\n        5.7    No Solicitation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.29<br \/>\n        5.8    Parent Standstill&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..32<br \/>\n        5.9    Public Disclosure&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..32<br \/>\n        5.10   Reasonable Efforts; Notification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..32<br \/>\n        5.11   Third Party Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..33<br \/>\n        5.12   401(k) Plan&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..34<br \/>\n        5.13   Disclosure Supplements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;34<br \/>\n        5.14   Indemnification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.34<\/p>\n<p>ARTICLE VI CONDITIONS TO THE MERGER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..34<\/p>\n<p>        6.1    Conditions to Obligations of Each Party to Effect the Merger&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.34<br \/>\n        6.2    Additional Conditions to Obligations of the Company&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.35<br \/>\n        6.3    Additional Conditions to the Obligations of Parent and Merger Sub&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..36<\/p>\n<p>ARTICLE VII TERMINATION, AMENDMENT AND WAIVER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.37<\/p>\n<p>        7.1    Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..37<br \/>\n        7.2    Notice of Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.39<br \/>\n        7.3    Effect of Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.39<br \/>\n        7.4    Fees and Expenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..41<br \/>\n        7.5    Amendment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.41<br \/>\n        7.6    Extension; Waiver&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..41<\/p>\n<p>ARTICLE VIII GENERAL PROVISIONS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;42<\/p>\n<p>        8.1    Survival of Representations and Warranties&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.42<br \/>\n        8.2    Notices&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;42<br \/>\n        8.3    Interpretation; Definitions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.43<br \/>\n        8.4    Counterparts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.43<br \/>\n        8.5    Entire Agreement; Third Party Beneficiaries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;43<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                      -ii-<br \/>\n   4<br \/>\n                               TABLE OF CONTENTS<br \/>\n                                  (CONTINUED)<\/p>\n<table>\n<caption>\n                                                                                                            PAGE<br \/>\n                                                                                                            &#8212;-<br \/>\n<s>                                                                                                          <c><br \/>\n        8.6    Severability&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.44<br \/>\n        8.7    Other Remedies; Specific Performance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.44<br \/>\n        8.8    Governing Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;44<br \/>\n        8.9    Rules of Construction&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.44<br \/>\n        8.10   Assignment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;44<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                INDEX OF EXHIBITS<\/p>\n<table>\n<s>                   <c><br \/>\n        Exhibit A     Form of Voting Agreement<\/p>\n<p>        Exhibit B     Form of Non-Competition Agreement<\/p>\n<p>        Exhibit C     Form of License Agreement<\/p>\n<p>        Exhibit D     Form of Omnibus Waiver and Amendment Agreement<\/p>\n<p>        Exhibit E     Form of Parent Warrant<\/p>\n<p>        Exhibit F     Form of Certificate of Merger<\/p>\n<p>        Exhibit G     Form of Amended and Restated Certificate of Incorporation of the Company<br \/>\n<\/c><\/s><\/table>\n<p>                                     -iii-<br \/>\n   5<\/p>\n<p>                 AGREEMENT AND PLAN OF MERGER AND REORGANIZATION<\/p>\n<p>        This AGREEMENT AND PLAN OF MERGER AND REORGANIZATION is made and entered<br \/>\ninto as of August 17, 2001, by and among VISX, Incorporated, a Delaware<br \/>\ncorporation (&#8220;Parent&#8221;), Orion Acquisition Corp., a Delaware corporation and a<br \/>\nwholly-owned subsidiary of Parent (&#8220;Merger Sub&#8221;), and Medjet Inc., a Delaware<br \/>\ncorporation (the &#8220;Company&#8221;).<\/p>\n<p>                                   BACKGROUND<\/p>\n<p>        A. Upon the terms and subject to the conditions of this Agreement (as<br \/>\ndefined in Section 1.2 below) and in accordance with the Delaware General<br \/>\nCorporation Law (&#8220;Delaware Law&#8221;), Parent and the Company intend to enter into a<br \/>\nbusiness combination transaction.<\/p>\n<p>        B. The Board of Directors of the Company (i) has determined that the<br \/>\nMerger (as defined in Section 1.1) is advisable and in the best interests of the<br \/>\nCompany and its stockholders, (ii) has approved and declared advisable this<br \/>\nAgreement, and has approved the Merger and the other transactions contemplated<br \/>\nby this Agreement and (iii) has determined to recommend that the stockholders of<br \/>\nthe Company adopt and approve this Agreement and approve the Merger.<\/p>\n<p>        C. The Boards of Directors of each of Parent and Merger Sub (i) have<br \/>\ndetermined that the Merger is advisable and in the best interests of Parent,<br \/>\nMerger Sub and their respective stockholders, and (ii) have approved this<br \/>\nAgreement, the Merger and the other transactions contemplated by this Agreement.<\/p>\n<p>        D. Each of the respective Boards of Directors of the Company, Parent and<br \/>\nMerger Sub recognizes that it is a condition of this Agreement, as set forth in<br \/>\nSection 7.1(a) below, that Parent may terminate this Agreement at any time, and<br \/>\nfor any reason or no reason. In consideration for such termination right, and as<br \/>\na material inducement to the Company to enter into this Agreement, Parent shall<br \/>\npay to the Company an amount equal to Five Hundred Thousand Dollars<br \/>\n($500,000.00), as described in Section 5.1 below, concurrently with the<br \/>\nexecution and delivery of this Agreement.<\/p>\n<p>        E. Concurrent with the execution and delivery of this Agreement, as a<br \/>\nmaterial inducement to Parent and Merger Sub to enter into this Agreement, (i)<br \/>\nEugene I. Gordon (the &#8220;Principal Shareholder&#8221;) is entering into a Voting<br \/>\nAgreement, in substantially the form attached as Exhibit A (the &#8220;Voting<br \/>\nAgreement&#8221;); (ii) the Principal Shareholder is entering into a Non-Competition<br \/>\nAgreement, in substantially the form attached as Exhibit B (the &#8220;Non-Competition<br \/>\nAgreement&#8221;); (iii) Parent and the Company are entering into a License Agreement,<br \/>\nin substantially the form attached as Exhibit C (the &#8220;License Agreement&#8221;); and<br \/>\n(iv) Parent and the Company are entering into an Omnibus Waiver and Amendment<br \/>\nAgreement, in substantially the form attached as Exhibit D (the &#8220;Omnibus Waiver<br \/>\nand Amendment Agreement&#8221;). The Voting Agreement, Non-Competition Agreement,<br \/>\nLicense Agreement and Omnibus Waiver and Amendment Agreement are collectively<br \/>\nreferred to as the &#8220;Related Agreements.&#8221;<\/p>\n<p>        F. Concurrent with the execution and delivery of this Agreement, Parent<br \/>\nis purchasing from entities affiliated with Adam Smith &amp; Co. (&#8220;ASC&#8221;): (i) 10,400<br \/>\nshares of the Company&#8217;s Series B Convertible Preferred Stock (the &#8220;Series B<br \/>\nPreferred&#8221;), which represent all of the Company&#8217;s<\/p>\n<p>   6<\/p>\n<p>outstanding shares of Preferred Stock, (ii) warrants to purchase a total of<br \/>\n1,040,000 shares of the Company&#8217;s Common Stock (the &#8220;Common Stock Warrants&#8221;),<br \/>\nand (iii) a warrant to purchase a total of 325,000 shares of the Company&#8217;s<br \/>\nCommon Stock (the &#8220;ASC Warrant&#8221;). At the Effective Time (as defined in Section<br \/>\n1.2 below), the 10,400 shares of Series B Preferred, the Common Stock Warrants<br \/>\nand the ASC Warrant will be canceled and extinguished without any conversion or<br \/>\nexercise thereof. If this Agreement is terminated pursuant to Article VII<br \/>\nhereof, then certain of Parent&#8217;s rights as the owner of the Series B Preferred,<br \/>\nthe Common Stock Warrants and ASC Warrant will be subject to certain<br \/>\nlimitations, as set forth more fully in Section 7.3 below.<\/p>\n<p>        G. Concurrent with the execution and delivery of this Agreement, as a<br \/>\nmaterial inducement to Parent and Merger Sub to enter into this Agreement, the<br \/>\nCompany is issuing and delivering to Parent a three-year warrant, in the form<br \/>\nattached as Exhibit E (the &#8220;Parent Warrant&#8221;) to purchase 1,320,000 shares of<br \/>\nCompany Common Stock at a per share exercise price of seventy-five cents<br \/>\n($0.75), as described more fully in Section 5.3 below. At the Effective Time (as<br \/>\ndefined in Section 1.2 below), the Parent Warrant will be canceled and<br \/>\nextinguished without any conversion or exercise thereof.<\/p>\n<p>        NOW, THEREFORE, in consideration of the covenants, promises and<br \/>\nrepresentations set forth in this Agreement, and for other good and valuable<br \/>\nconsideration, the receipt and sufficiency of which are hereby acknowledged, the<br \/>\nparties agree as follows:<\/p>\n<p>                                    ARTICLE I<br \/>\n                                   THE MERGER<\/p>\n<p>        1.1 The Merger. At the Effective Time (as defined in Section 1.2) and<br \/>\nsubject to and upon the terms and conditions of this Agreement and the<br \/>\napplicable provisions of Delaware Law, Merger Sub shall be merged with and into<br \/>\nthe Company (the &#8220;Merger&#8221;), the separate corporate existence of Merger Sub shall<br \/>\ncease and the Company shall continue as the surviving corporation. The Company<br \/>\nas the surviving corporation after the Merger is sometimes referred to as the<br \/>\n&#8220;Surviving Corporation.&#8221;<\/p>\n<p>        1.2 Effective Time; Closing. Subject to the provisions of this<br \/>\nAgreement, the parties shall cause the Merger to be consummated by filing a<br \/>\nCertificate of Merger, in the form attached as Exhibit F with the Secretary of<br \/>\nState of the State of Delaware in accordance with the relevant provisions of<br \/>\nDelaware Law (the &#8220;Certificate of Merger&#8221;) (the time of such filing (or such<br \/>\nlater time, as may be agreed in writing by the Company and Parent and specified<br \/>\nin the Certificate of Merger) being the &#8220;Effective Time&#8221;) as soon as practicable<br \/>\non the Closing Date (as defined below). Unless the context otherwise requires,<br \/>\nthe term &#8220;Agreement&#8221; refers collectively to this Agreement and Plan of Merger<br \/>\nand Reorganization and the Certificate of Merger. The closing of the Merger (the<br \/>\n&#8220;Closing&#8221;) shall take place at either (in Parent&#8217;s option) the offices of Kelley<br \/>\nDrye &amp; Warren LLP, 101 Park Avenue, New York, New York or Wilson Sonsini<br \/>\nGoodrich &amp; Rosati, Professional Corporation, 245 Park Avenue, New York, New<br \/>\nYork, after satisfaction or waiver of all conditions to Closing set forth in<br \/>\nArticle VI, including without limitation satisfaction in Parent&#8217;s sole<br \/>\ndiscretion of the closing condition set forth in Section 6.3(m); provided,<br \/>\nhowever, that the Closing shall occur no sooner than five business days after<br \/>\ndelivery of the written certificate referred to in such section (the &#8220;Closing<br \/>\nDate&#8221;).<\/p>\n<p>                                      -2-<br \/>\n   7<\/p>\n<p>        1.3 Effects of the Merger. At the Effective Time, the effects of the<br \/>\nMerger shall be as provided in this Agreement and the applicable provisions of<br \/>\nDelaware Law. Without limiting the generality of the foregoing, and subject<br \/>\nthereto, at the Effective Time all the property, rights, privileges, powers and<br \/>\nfranchises of the Company and Merger Sub shall vest in the Surviving<br \/>\nCorporation, and all debts, liabilities and duties of the Company and Merger Sub<br \/>\nshall become the debts, liabilities and duties of the Surviving Corporation.<\/p>\n<p>        1.4 Certificate of Incorporation; Bylaws.<\/p>\n<p>                (a) At the Effective Time, the Certificate of Incorporation of<br \/>\nthe Merger Sub, as in effect immediately prior to the Effective Time, shall be<br \/>\nthe Certificate of Incorporation of the Surviving Corporation until thereafter<br \/>\namended as provided by law and such Certificate of Incorporation of the<br \/>\nSurviving Corporation; provided, however, that at the Effective Time the<br \/>\nCertificate of Incorporation of the Surviving Corporation shall be amended and<br \/>\nrestated in the form attached as Exhibit G.<\/p>\n<p>                (b) The Bylaws of Merger Sub, as in effect immediately prior to<br \/>\nthe Effective Time, shall be, at the Effective Time, the Bylaws of the Surviving<br \/>\nCorporation until thereafter amended.<\/p>\n<p>        1.5 Directors and Officers. The initial directors of the Surviving<br \/>\nCorporation shall be the directors of Merger Sub immediately prior to the<br \/>\nEffective Time, until their respective successors are duly elected or appointed<br \/>\nand qualified. The initial officers of the Surviving Corporation shall be the<br \/>\nofficers of Merger Sub immediately prior to the Effective Time, until their<br \/>\nrespective successors are duly appointed.<\/p>\n<p>        1.6 Effect on Capital Stock. Subject to the terms and conditions of this<br \/>\nAgreement, at the Effective Time, by virtue of the Merger and without any action<br \/>\non the part of Merger Sub, the Company or the holders of any of the following<br \/>\nsecurities, the following shall occur:<\/p>\n<p>                (a) Conversion of Company Common Stock. At the Effective Time,<br \/>\neach outstanding share of common stock of the Company (&#8220;Company Common Stock&#8221;),<br \/>\nupon the terms and subject to the conditions set forth below and throughout this<br \/>\nAgreement, will be canceled and extinguished and be converted automatically into<br \/>\nthe right to receive Two Dollars ($2.00) (the &#8220;Per Share Purchase Price&#8221;), upon<br \/>\nthe terms and subject to conditions set forth in this Section 1.6 and throughout<br \/>\nthis Agreement. The Per Share Purchase Price shall be appropriately adjusted to<br \/>\nreflect fully the effect of any stock split, reverse stock split, stock<br \/>\ndividend, reorganization, recapitalization or like change with respect to<br \/>\nCompany Common Stock occurring after the date hereof and prior to the Effective<br \/>\nTime (a &#8220;Recapitalization&#8221;).<\/p>\n<p>                (b) Cancellation of Parent-Owned Stock and Securities. Each<br \/>\nshare of Company capital stock and all warrants to purchase Company capital<br \/>\nstock held by the Company or owned by Merger Sub, Parent or any direct or<br \/>\nindirect wholly-owned subsidiary of the Company or of Parent immediately prior<br \/>\nto the Effective Time shall be canceled and extinguished without any conversion<br \/>\nthereof.<\/p>\n<p>                                      -3-<br \/>\n   8<\/p>\n<p>                (c) Stock Options and Warrants. At the Effective Time, each<br \/>\noutstanding option to purchase shares of Company Common Stock (each, a &#8220;Company<br \/>\nStock Option&#8221;) under the Company&#8217;s 1994 Stock Option Plan (the &#8220;Company Option<br \/>\nPlan&#8221;) or otherwise and each outstanding warrant to purchase shares of Company<br \/>\nCommon Stock (each, a &#8220;Company Warrant&#8221;) not exercised prior to the Effective<br \/>\nTime shall be canceled and extinguished. Parent will pay to each holder of a<br \/>\nCompany Stock Option or a Company Warrant the difference between $2.00 and the<br \/>\nexercise price per share (if less than $2.00) of Company Common Stock underlying<br \/>\nsuch Company Stock Option or Company Warrant multiplied by the total number of<br \/>\nshares of Company Common Stock underlying such Company Stock Option or Company<br \/>\nWarrant (other than any Company Warrant held by Parent). Parent will not pay any<br \/>\namounts with respect to Company Stock Options or Company Warrants that have an<br \/>\nexercise price of equal to or greater than $2.00.<\/p>\n<p>                (d) Capital Stock of Merger Sub. Each share of common stock of<br \/>\nMerger Sub (the &#8220;Merger Sub Common Stock&#8221;) issued and outstanding immediately<br \/>\nprior to the Effective Time shall be converted into one validly issued, fully<br \/>\npaid and nonassessable share of common stock of the Surviving Corporation. Each<br \/>\ncertificate evidencing ownership of shares of Merger Sub Common Stock shall<br \/>\nevidence ownership of such shares of capital stock of the Surviving Corporation.<br \/>\nAccordingly, as a result of the Merger, Parent (as the owner of all outstanding<br \/>\nshares of Merger Sub Common Stock immediately prior to the Effective Time) shall<br \/>\nbe the owner of all of the capital stock of the Surviving Corporation<br \/>\nimmediately after the Effective Time.<\/p>\n<p>                (e) Shareholder Loans. In the event that any holder of Company<br \/>\nCommon Stock has outstanding loans owed to the Company as of the Effective Time,<br \/>\nthe consideration payable to such holder of Company Common Stock pursuant to<br \/>\nthis Section 1.6 shall be reduced by an amount equal to the outstanding<br \/>\nprincipal plus accrued interest of such holder&#8217;s loans as of the Effective Time.<br \/>\nThe reduction in the consideration contemplated in the preceding sentence is<br \/>\nintended to effect a payment mechanism for the satisfaction and not the<br \/>\nforgiveness of any such outstanding loan.<\/p>\n<p>        1.7 Dissenting Shares.<\/p>\n<p>                (a) Notwithstanding any other provisions of this Agreement to<br \/>\nthe contrary, any shares of Company Common Stock held by a holder who has<br \/>\nexercised and perfected appraisal rights for such shares in accordance with<br \/>\nSection 262 of Delaware Law and who has not effectively withdrawn or lost such<br \/>\nappraisal rights (&#8220;Dissenting Shares&#8221;), shall not be converted into or represent<br \/>\na right to receive the consideration for Company Common Stock set forth in<br \/>\nSection 1.6 hereof, but the holder thereof shall only be entitled to such rights<br \/>\nas are provided by Delaware Law.<\/p>\n<p>                (b) Notwithstanding the provisions of Section 1.7(a) hereof, if<br \/>\nany holder of Dissenting Shares shall effectively withdraw or lose (through<br \/>\nfailure to perfect or otherwise) such holder&#8217;s appraisal rights under Delaware<br \/>\nLaw, then, as of the later of the Effective Time and the occurrence of such<br \/>\nevent, such holder&#8217;s shares shall automatically be converted into and represent<br \/>\nonly the right to receive the consideration for Company Common Stock set forth<br \/>\nin Section 1.6 hereof, without interest thereon, upon surrender of the<br \/>\ncertificate representing such shares.<\/p>\n<p>                                      -4-<br \/>\n   9<\/p>\n<p>                (c) The Company shall give Parent (i) prompt notice of any<br \/>\nwritten demand for appraisal received by the Company pursuant to the applicable<br \/>\nprovisions of Delaware Law, and (ii) the opportunity to participate in all<br \/>\nnegotiations and proceedings with respect to such demands. The Company shall<br \/>\nnot, except with the prior written consent of Parent, make any payment with<br \/>\nrespect to any such demands or offer to settle or settle any such demands.<\/p>\n<p>        1.8 Surrender of Certificates.<\/p>\n<p>                (a) Exchange Agent. Parent shall select a bank or trust company<br \/>\nreasonably acceptable to the Company to act as the exchange agent (the &#8220;Exchange<br \/>\nAgent&#8221;) in the Merger.<\/p>\n<p>                (b) Parent to Provide Aggregate Consideration. Promptly after<br \/>\nthe Effective Time, Parent shall make available to the Exchange Agent for<br \/>\nexchange in accordance with this Article I, the Aggregate Consideration payable<br \/>\npursuant to Section 1.6 in exchange for outstanding shares of Company Common<br \/>\nStock. &#8220;Aggregate Consideration&#8221; shall mean the sum total of the amounts payable<br \/>\nin exchange for outstanding shares of Company Common Stock pursuant to Section<br \/>\n1.6.<\/p>\n<p>                (c) Exchange Procedures. As soon as practicable after the<br \/>\nEffective Time, Parent shall cause the Exchange Agent to mail to each holder of<br \/>\nrecord (as of the Effective Time) of a certificate or certificates (the<br \/>\n&#8220;Certificates&#8221;), which immediately prior to the Effective Time represented<br \/>\noutstanding shares of Company Common Stock whose shares were converted into the<br \/>\nright to receive the amounts payable pursuant to Section 1.6, (i) a letter of<br \/>\ntransmittal in customary form (which shall specify that delivery shall be<br \/>\neffected, and risk of loss and title to the Certificates shall pass, only upon<br \/>\ndelivery of the Certificates to the Exchange Agent and shall contain such other<br \/>\nprovisions as Parent may reasonably specify) and (ii) instructions for use in<br \/>\neffecting the surrender of the Certificates in exchange for the amounts payable<br \/>\npursuant to Section 1.6. Upon surrender of Certificates for cancellation to the<br \/>\nExchange Agent or to such other agent or agents as may be appointed by Parent,<br \/>\ntogether with such letter of transmittal, duly completed and validly executed in<br \/>\naccordance with the instructions thereto, the holders of such Certificates shall<br \/>\nbe entitled to receive the amounts payable pursuant to Section 1.6, and the<br \/>\nCertificates so surrendered shall forthwith be canceled. Until so surrendered,<br \/>\nthe outstanding Certificates will be deemed from and after the Effective Time,<br \/>\nfor all corporate purposes to evidence only the right to receive the amounts<br \/>\npayable pursuant to Section 1.6.<\/p>\n<p>                (d) Required Withholding. Any of the Exchange Agent, Parent or<br \/>\nthe Surviving Corporation, as the case may be, shall be entitled to deduct and<br \/>\nwithhold from any consideration payable or otherwise deliverable pursuant to<br \/>\nthis Agreement to any holder or former holder of Company Common Stock such<br \/>\namounts as may be required to be deducted or withheld therefrom under the<br \/>\nInternal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) or under any provision of<br \/>\nstate, local or foreign tax law or under any other applicable legal requirement.<br \/>\nTo the extent such amounts are so deducted or withheld, such amounts shall be<br \/>\ntreated for all purposes under this Agreement as having been paid to the person<br \/>\nto whom such amounts would otherwise have been paid.<\/p>\n<p>                (e) No Liability. Notwithstanding anything to the contrary in<br \/>\nthis Section 1.8, neither the Exchange Agent, Parent, the Surviving Corporation<br \/>\nnor any party shall be liable to a<\/p>\n<p>                                      -5-<br \/>\n   10<\/p>\n<p>holder of shares of Company Common Stock for any amount properly paid to a<br \/>\npublic official pursuant to any applicable abandoned property, escheat or<br \/>\nsimilar law.<\/p>\n<p>        1.9 No Further Ownership Rights in Company Common Stock. The Aggregate<br \/>\nConsideration shall be deemed to have been paid in full satisfaction of all<br \/>\nrights pertaining to shares of Company Common Stock, and there shall be no<br \/>\nfurther registration of transfers on the records of the Surviving Corporation of<br \/>\nshares of Company Common Stock that were outstanding immediately prior to the<br \/>\nEffective Time. If, after the Effective Time, Certificates are presented to the<br \/>\nSurviving Corporation for any reason, they shall be canceled and exchanged as<br \/>\nprovided in this Article I.<\/p>\n<p>        1.10 Lost, Stolen or Destroyed Certificates. In the event that any<br \/>\nCertificates shall have been lost, stolen or destroyed, the Exchange Agent shall<br \/>\npay the amounts payable pursuant to Section 1.6 in exchange for such lost,<br \/>\nstolen or destroyed Certificates, upon the making of an affidavit of that fact<br \/>\nby the holder thereof; provided, however, that Parent may, in its reasonable<br \/>\ndiscretion and as a condition precedent to the payment of the amounts payable<br \/>\npursuant to Section 1.6, require the owner of such lost, stolen or destroyed<br \/>\nCertificates to deliver a bond in such sum as it may reasonably direct as<br \/>\nindemnity against any claim that may be made against Parent, the Surviving<br \/>\nCorporation or the Exchange Agent with respect to the Certificates alleged to<br \/>\nhave been lost, stolen or destroyed.<\/p>\n<p>        1.11 Taking of Necessary Action; Further Action. If, at any time after<br \/>\nthe Effective Time, any further action is necessary or desirable to carry out<br \/>\nthe purposes of this Agreement and to vest the Surviving Corporation with full<br \/>\nright, title and possession to all assets, property, rights, privileges, powers<br \/>\nand franchises of the Company and Merger Sub, the current officers and directors<br \/>\nof the Company and Merger Sub will, to the extent reasonable and at the sole<br \/>\nexpense of the Surviving Corporation, take all such lawful and necessary action.<\/p>\n<p>                                   ARTICLE II<br \/>\n                    REPRESENTATIONS AND WARRANTIES OF COMPANY<\/p>\n<p>        The Company represents and warrants to Parent and Merger Sub as follows,<br \/>\nsubject to such exceptions as are specifically disclosed in writing in the<br \/>\ndisclosure schedule supplied by the Company to Parent dated as of the date<br \/>\nhereof (the &#8220;Company Schedule&#8221;). The Company Schedule shall be arranged in<br \/>\nsections corresponding to the numbered and lettered paragraphs contained in this<br \/>\nArticle II, and the disclosure of any section of the Company Schedule shall<br \/>\nqualify other paragraphs in this Article II only to the extent that it is<br \/>\nreasonably apparent from a reading of such disclosure that it also qualifies or<br \/>\napplies to such other paragraph.<\/p>\n<p>        2.1 Organization and Qualification; Subsidiaries.<\/p>\n<p>                (a) The Company is a corporation duly organized, validly<br \/>\nexisting and in good standing under the laws of the jurisdiction of its<br \/>\nincorporation and has the requisite corporate power and authority to own, lease<br \/>\nand operate its assets and properties and to carry on its business as it is now<br \/>\nbeing conducted. The Company is in possession of all franchises, grants,<br \/>\nauthorizations, licenses, permits, easements, consents, certificates, approvals<br \/>\nand orders (&#8220;Approvals&#8221;) necessary to own, lease and operate the properties it<br \/>\npurports to own, operate or lease and to carry on its business<\/p>\n<p>                                      -6-<br \/>\n   11<\/p>\n<p>as it is now being conducted, except where the failure to have such Approvals<br \/>\nwould not, individually or in the aggregate, be material to the Company. The<br \/>\nCompany is duly qualified or licensed as a foreign corporation to do business,<br \/>\nand is in good standing, in each jurisdiction where the character of the<br \/>\nproperties owned, leased or operated by it or the nature of its activities makes<br \/>\nsuch qualification or licensing necessary, except for such failures to be so<br \/>\nduly qualified or licensed and in good standing that would not, either<br \/>\nindividually or in the aggregate, have a Material Adverse Effect on the Company.<\/p>\n<p>                (b) The Company has no subsidiaries. The Company has not agreed<br \/>\nnor is obligated to make nor be bound by any written, oral or other agreement,<br \/>\ncontract, subcontract, lease, binding understanding, instrument, note, option,<br \/>\nwarranty, purchase order, license, sublicense, insurance policy, benefit plan,<br \/>\ncommitment or undertaking of any nature, as of the date hereof or as may<br \/>\nhereafter be in effect (a &#8220;Contract&#8221;) under which it may become obligated to<br \/>\nmake, any future investment in or capital contribution to any other entity. The<br \/>\nCompany does not directly or indirectly own any equity or similar interest in or<br \/>\nany interest convertible, exchangeable or exercisable for, any equity or similar<br \/>\ninterest in, any corporation, partnership, joint venture or other business,<br \/>\nassociation or entity.<\/p>\n<p>        2.2 Certificate of Incorporation and Bylaws. The Company has previously<br \/>\nfurnished to Parent a complete and correct copy of its certificate of<br \/>\nincorporation and bylaws as amended to date (together, the &#8220;Company Charter<br \/>\nDocuments&#8221;). Such Company Charter Documents are in full force and effect. The<br \/>\nCompany is not in violation of any of the provisions of the Company Charter<br \/>\nDocuments.<\/p>\n<p>        2.3 Capitalization.<\/p>\n<p>                (a) The authorized capital stock of the Company consists of:<br \/>\n30,000,000 shares of Company Common Stock, and 1,000,000 shares of Preferred<br \/>\nStock (&#8220;Company Preferred Stock&#8221;), which may be designated as Series A Preferred<br \/>\nStock, Series B Preferred Stock, Series C Preferred Stock, and Series B<br \/>\nConvertible Preferred Stock. The Series A Preferred Stock, Series B Preferred<br \/>\nStock and Series C Preferred Stock consist of an aggregate of not more than<br \/>\n400,000 shares, of which 110,000 are designated as Series A Preferred Stock. In<br \/>\naddition, 16,000 shares of Company Preferred Stock are designated as Series B<br \/>\nConvertible Preferred Stock, each having par value $0.01 per share. At the close<br \/>\nof business on August 14, 2001:<\/p>\n<p>                        (i) 3,901,431 shares of Company Common Stock were issued<br \/>\nand outstanding, all of which are validly issued, fully paid and nonassessable;<\/p>\n<p>                        (ii) no shares of Series A Preferred Stock were issued<br \/>\nor outstanding;<\/p>\n<p>                        (iii) no shares of Series B Preferred Stock were issued<br \/>\nor outstanding;<\/p>\n<p>                        (iv) no shares of Series C Preferred Stock were issued<br \/>\nor outstanding;<\/p>\n<p>                        (v) 10,400 shares of Series B Convertible Preferred<br \/>\nStock were issued and outstanding, all of which are validly issued, fully paid<br \/>\nand nonassessable;<\/p>\n<p>                                      -7-<br \/>\n   12<\/p>\n<p>                        (vi) 33,789 shares of Company Common Stock were held in<br \/>\ntreasury by the Company;<\/p>\n<p>                        (vii) 513,046 shares of Company Common Stock were<br \/>\nreserved for issuance upon the exercise of outstanding options to purchase<br \/>\nCompany Common Stock under the Company Option Plan;<\/p>\n<p>                        (viii) no shares of Company Common Stock were reserved<br \/>\nfor issuance upon the exercise of other outstanding options to purchase Company<br \/>\nCommon Stock;<\/p>\n<p>                        (ix) 133,531 shares of Company Common Stock were<br \/>\navailable for future grant under the Company Option Plan;<\/p>\n<p>                        (x) 1,440,772 shares of Company Common Stock were<br \/>\nreserved for future issuance upon conversion of warrants of the Company.<\/p>\n<p>                (b) Section 2.3(b) of the Company Schedule sets forth the<br \/>\nfollowing information with respect to each Company Stock Option outstanding as<br \/>\nof August 14, 2001: (i) the name of the optionee; (ii) the particular plan<br \/>\npursuant to which such Company Stock Option was granted; (iii) the number of<br \/>\nshares of Company Common Stock subject to such Company Stock Option; (iv) the<br \/>\nexercise price of such Company Stock Option; (v) the date on which such Company<br \/>\nStock Option was granted; (vi) the applicable vesting schedule; and (vii) the<br \/>\ndate on which such Company Stock Option expires. The Company has made available<br \/>\nto Parent accurate and complete copies of all stock option plans pursuant to<br \/>\nwhich the Company has granted such Company Stock Options that are currently<br \/>\noutstanding and the form of all stock option agreements evidencing such Company<br \/>\nStock Options. Section 2.3(b) of the Company Schedule also sets forth the<br \/>\nfollowing information with respect to each Company Warrant outstanding as of<br \/>\nAugust 14, 2001: (i) the name of the warrant holder; (ii) the number of shares<br \/>\nof Company Common Stock subject to such Company Warrant; (iii) the exercise<br \/>\nprice of such Company Warrant; (iv) the date on which such Company Warrant was<br \/>\ngranted; (v) any applicable performance based provisions of such Company<br \/>\nWarrant; (vi) the date on which such Company Warrant expires. All shares of<br \/>\nCompany Common Stock subject to issuance as aforesaid, upon issuance on the<br \/>\nterms and conditions specified in the instrument pursuant to which they are<br \/>\nissuable, would be duly authorized, validly issued, fully paid and<br \/>\nnonassessable. Except as set forth in Section 2.3(b) of the Company Schedule,<br \/>\nthere are no commitments or agreements of any character to which the Company is<br \/>\nbound obligating the Company to accelerate the vesting of any Company Stock<br \/>\nOption or Company Warrants as a result of the Merger. All outstanding shares of<br \/>\nCompany Common Stock and all outstanding Company Stock Options have been issued<br \/>\nand granted in compliance with (i) all applicable securities laws and other<br \/>\napplicable Legal Requirements (as defined below) and (ii) all requirements set<br \/>\nforth in applicable Contracts. For the purposes of this Agreement, &#8220;Legal<br \/>\nRequirements&#8221; means any federal, state, local, municipal, foreign or other law,<br \/>\nstatute, constitution, principle of common law, resolution, ordinance, code,<br \/>\nedict, decree, rule, regulation, ruling or requirement issued, enacted, adopted,<br \/>\npromulgated, implemented or otherwise put into effect by or under the authority<br \/>\nof any Governmental Entity (as defined below).<\/p>\n<p>                (c) Except as set forth in Section 2.3(b) of the Company<br \/>\nSchedule, there are no subscriptions, options, warrants, equity securities,<br \/>\npartnership interests or similar ownership<\/p>\n<p>                                      -8-<br \/>\n   13<\/p>\n<p>interests, calls, rights (including preemptive rights), commitments or<br \/>\nagreements of any character to which the Company is a party or by which it is<br \/>\nbound obligating the Company to issue, deliver or sell, or cause to be issued,<br \/>\ndelivered or sold, or repurchase, redeem or otherwise acquire, or cause the<br \/>\nrepurchase, redemption or acquisition of, any shares of capital stock,<br \/>\npartnership interests or similar ownership interests of the Company or<br \/>\nobligating the Company to grant, extend, accelerate the vesting of or enter into<br \/>\nany such subscription, option, warrant, equity security, call, right, commitment<br \/>\nor agreement. As of the date of this Agreement, there are no registration rights<br \/>\nand there is, except for the Voting Agreement, no voting trust, proxy, rights<br \/>\nplan, antitakeover plan or other agreement or understanding to which the Company<br \/>\nis a party or by which it is bound with respect to any equity security of any<br \/>\nclass of the Company.<\/p>\n<p>        2.4 Authority Relative to this Agreement. The Company has all necessary<br \/>\ncorporate power and authority to execute and deliver this Agreement and the<br \/>\nRelated Agreements and to perform its obligations hereunder and thereunder,<br \/>\nsubject to obtaining the approval of the stockholders of the Company of the<br \/>\nMerger and this Agreement, to consummate the transactions contemplated hereby<br \/>\nand thereby. The execution and delivery of this Agreement by the Company and the<br \/>\nconsummation by the Company of the transactions contemplated hereby and the<br \/>\nexecution and delivery of the Related Agreements by the Company and the<br \/>\nconsummation by the Company of the transactions contemplated thereby have been<br \/>\nduly and validly authorized by all necessary corporate action on the part of the<br \/>\nCompany, and no other corporate proceedings on the part of the Company are<br \/>\nnecessary to authorize this Agreement and the Related Agreements, or to<br \/>\nconsummate the transactions so contemplated (other than, with respect to the<br \/>\nMerger, the approval and adoption of the Merger and this Agreement by a majority<br \/>\nof the votes entitled to be cast by the holders of the Company Common Stock and<br \/>\nSeries B Convertible Preferred Stock (voting on an as-converted to Company<br \/>\nCommon Stock basis), voting together as a single class, in accordance with<br \/>\nDelaware Law and the Company Charter Documents). This Agreement and the Related<br \/>\nAgreements have been duly and validly executed and delivered by the Company and,<br \/>\nassuming the due authorization, execution and delivery by Parent and Merger Sub,<br \/>\nand subject to obtaining the approval of the Company&#8217;s stockholders of the<br \/>\nMerger and this Agreement, constitute legal and binding obligations of the<br \/>\nCompany, enforceable against the Company in accordance with their terms except<br \/>\nas enforceability may be limited by applicable bankruptcy, insolvency,<br \/>\nreorganization, moratorium or similar laws affecting creditors&#8217; and contracting<br \/>\nparties&#8217; rights generally and except as enforceability may be subject to general<br \/>\nprinciples of equity (regardless of whether such enforceability is considered in<br \/>\na proceeding in equity or at law).<\/p>\n<p>        2.5 No Conflict; Required Filings and Consents.<\/p>\n<p>                (a) The execution and delivery of this Agreement and the Related<br \/>\nAgreements by the Company do not, and the performance of this Agreement and the<br \/>\nRelated Agreements by the Company shall not, (i) conflict with or violate the<br \/>\nCompany Charter Documents, (ii) subject to obtaining the approval of the<br \/>\nCompany&#8217;s stockholders of the Merger and this Agreement and compliance with the<br \/>\nrequirements set forth in Section 2.5(b) below, conflict with or violate any<br \/>\nlaw, rule, regulation, order, judgment or decree applicable to the Company by<br \/>\nwhich its properties is bound or affected, or (iii) result in any breach of or<br \/>\nconstitute a default (or an event that with notice or lapse of time or both<br \/>\nwould become a default) under, or impair the Company&#8217;s rights or alter the<br \/>\nrights or obligations of any third party under, or give to others any rights of<br \/>\ntermination, amendment,<\/p>\n<p>                                      -9-<br \/>\n   14<\/p>\n<p>acceleration or cancellation of, or result in the creation of a lien or<br \/>\nencumbrance on any of the properties or assets of the Company pursuant to, any<br \/>\nmaterial note, bond, mortgage, indenture, contract, agreement, lease, license,<br \/>\npermit, franchise or other instrument or obligation to which the Company is a<br \/>\nparty or by which the Company or its respective properties are bound or<br \/>\naffected, except to the extent such conflict, violation, breach, default,<br \/>\nimpairment or other effect could not in the case of clauses (ii) or (iii),<br \/>\nindividually or in the aggregate, reasonably be expected to have a Material<br \/>\nAdverse Effect on the Company.<\/p>\n<p>                (b) The execution and delivery of this Agreement and the Related<br \/>\nAgreements by the Company do not, and the performance of this Agreement and the<br \/>\nRelated Agreements by the Company shall not, require any consent, approval,<br \/>\nauthorization or permit of, or filing with or notification to, any court,<br \/>\nadministrative agency, commission, governmental or regulatory authority,<br \/>\ndomestic or foreign (a &#8220;Governmental Entity&#8221;), except (A) for applicable<br \/>\nrequirements, if any, of the Securities Act of 1933, as amended (the &#8220;Securities<br \/>\nAct&#8221;), the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;),<br \/>\nstate securities laws (&#8220;Blue Sky Laws&#8221;), the pre-merger notification<br \/>\nrequirements (the &#8220;HSR Approval&#8221;) of the Hart-Scott-Rodino Antitrust<br \/>\nImprovements Act of 1976, as amended (the &#8220;HSR Act&#8221;), the rules and regulations<br \/>\nof Nasdaq, and the filing and recordation of the Certificate of Merger as<br \/>\nrequired by Delaware Law and (B) where the failure to obtain such consents,<br \/>\napprovals, authorizations or permits, or to make such filings or notifications,<br \/>\nwould not have a material adverse effect on the Company&#8217;s ability to consummate<br \/>\nthe Merger or perform its obligations under this Agreement or the Related<br \/>\nAgreements.<\/p>\n<p>        2.6 Compliance; Permits.<\/p>\n<p>                (a) The Company is not in default or violation of, (i) any law,<br \/>\nrule, regulation, order, judgment or decree (each, a &#8220;Law&#8221;) applicable to the<br \/>\nCompany or by which its properties is bound or affected, or (ii) any material<br \/>\nnote, bond, mortgage, indenture, contract, agreement, lease, license, permit,<br \/>\nfranchise or other instrument or obligation to which the Company is a party or<br \/>\nby which the Company or its properties is bound or affected, except for any<br \/>\ndefaults or violations that (individually or in the aggregate) would not have a<br \/>\nMaterial Adverse Effect on the Company. To the Company&#8217;s knowledge no<br \/>\ninvestigation or review by any governmental or regulatory body or authority is<br \/>\npending or threatened against the Company, nor has any governmental or<br \/>\nregulatory body or authority indicated an intention to conduct the same, other<br \/>\nthan, in each such case, those the outcome of which could not, individually or<br \/>\nin the aggregate, reasonably be expected to have the effect of prohibiting or<br \/>\nmaterially impairing any business practice of the Company, any acquisition of<br \/>\nmaterial property by the Company or the conduct of business by the Company in<br \/>\nany material way.<\/p>\n<p>                (b) The Company holds all permits, licenses, variances,<br \/>\nexemptions, orders and approvals from governmental authorities (&#8220;Permits&#8221;) that<br \/>\nare material to operation of the business of the Company as currently conducted<br \/>\n(collectively, the &#8220;Company Permits&#8221;); provided, however, that Permits that may<br \/>\nbe required for the future operation of the business have not been granted by<br \/>\nthe Food and Drug Administration or any comparable foreign governmental entity.<br \/>\nThe Company is in compliance in all material respects with the terms of the<br \/>\nCompany Permits.<\/p>\n<p>        2.7 SEC Filings; Financial Statements.<\/p>\n<p>                                      -10-<br \/>\n   15<\/p>\n<p>                (a) The Company has made available to Parent a correct and<br \/>\ncomplete copy of each report, schedule, registration statement and definitive<br \/>\nproxy statement filed by the Company with the Securities and Exchange Commission<br \/>\n(&#8220;SEC&#8221;) after January 1, 1999 (the &#8220;Company SEC Reports&#8221;), which are all the<br \/>\nforms, reports and documents required to be filed by the Company with the SEC<br \/>\nafter January 1, 1999. The Company SEC Reports (A) were prepared in accordance<br \/>\nwith the requirements of the Securities Act or the Exchange Act, as the case may<br \/>\nbe, and filed on a timely basis and (B) did not at the time they were filed (and<br \/>\nif amended or superseded by a filing prior to the date of this Agreement then on<br \/>\nthe date of such filing) contain any untrue statement of a material fact or omit<br \/>\nto state a material fact required to be stated therein or necessary in order to<br \/>\nmake the statements therein, in light of the circumstances under which they were<br \/>\nmade, not misleading.<\/p>\n<p>                (b) Each set of consolidated financial statements (including, in<br \/>\neach case, any related notes thereto) contained in the Company SEC Reports was<br \/>\nprepared in accordance with generally accepted accounting principles (&#8220;GAAP&#8221;)<br \/>\napplied on a consistent basis throughout the periods involved (except as may be<br \/>\nindicated in the notes thereto or, in the case of unaudited statements, for the<br \/>\nabsence of footnotes) and each fairly presents in all material respects the<br \/>\nfinancial position of the Company at the respective dates thereof and the<br \/>\nresults of its operations and cash flows for the periods indicated, except that<br \/>\nthe unaudited interim financial statements were or are subject to normal<br \/>\nadjustments and lack footnotes.<\/p>\n<p>        2.8 No Undisclosed Liabilities. The Company has no liabilities<br \/>\n(absolute, accrued, contingent or otherwise) which are, individually or in the<br \/>\naggregate, material to the business, results of operations or financial<br \/>\ncondition of the Company taken as a whole, except (i) liabilities provided for<br \/>\nin the Company&#8217;s balance sheet as of December 31, 2000 (or described in the<br \/>\nfootnotes thereto), (ii) liabilities incurred since December 31, 2000 in the<br \/>\nordinary course of business, (iii) contractual and other liabilities incurred in<br \/>\nthe ordinary course of business which are not required by GAAP to be reflected<br \/>\non a balance sheet, and (iv) liabilities permitted under this Agreement and the<br \/>\ntransactions related to the Merger, and liabilities incurred pursuant to or in<br \/>\nconnection with any other agreement between the parties.<\/p>\n<p>        2.9 Absence of Certain Changes or Events. Since March 31, 2001, there<br \/>\nhas not been: (i) any declaration, setting aside or payment of any dividend on,<br \/>\nor other distribution (whether in cash, stock or property) in respect of, any of<br \/>\nthe Company&#8217;s capital stock, (ii) any purchase, redemption or other acquisition<br \/>\nby the Company of (a) the Company&#8217;s capital stock, (b) any other securities of<br \/>\nthe Company or (c) any options, warrants, calls or rights to acquire any such<br \/>\nshares or other securities, except for repurchases from employees following<br \/>\ntheir termination pursuant to the terms of their pre-existing stock option or<br \/>\npurchase agreements, (iii) any split, combination or reclassification of any of<br \/>\nthe Company&#8217;s capital stock, (iv) any granting by the Company of any increase in<br \/>\ncompensation or fringe benefits, except for normal increases of cash<br \/>\ncompensation to non-officer employees in the ordinary course of business<br \/>\nconsistent with past practice, or any payment by the Company of any bonus,<br \/>\nexcept for bonuses made to non-officer employees in the ordinary course of<br \/>\nbusiness consistent with past practice, or any granting by the Company of any<br \/>\nincrease in severance or termination pay or any entry by the Company into any<br \/>\ncurrently effective employment, severance, termination or indemnification<br \/>\nagreement or any agreement the benefits of which are contingent or the terms of<br \/>\nwhich are materially altered upon the occurrence of a transaction involving the<br \/>\nCompany of the nature contemplated hereby, (v) except for any agreements<\/p>\n<p>                                      -11-<br \/>\n   16<\/p>\n<p>between Parent and the Company, entry by the Company into any licensing or other<br \/>\nagreement with regard to the acquisition or disposition of any Company<br \/>\nIntellectual Property (as defined in Section 2.19) other than any amendment or<br \/>\nconsent with respect to any licensing agreement filed or required to be filed by<br \/>\nthe Company with the SEC, (vi) any material change by the Company in its<br \/>\naccounting methods, principles or practices, except as required by concurrent<br \/>\nchanges in GAAP, or (vii) any revaluation by the Company of any of its assets,<br \/>\nincluding, without limitation, writing down the value of capitalized inventory<br \/>\nor writing off notes or accounts receivable or any sale of assets of the Company<br \/>\nother than in the ordinary course of business.<\/p>\n<p>        2.10 Absence of Litigation. There are no claims, actions, suits or<br \/>\nproceedings (&#8220;Claims&#8221;) pending or, to the knowledge of the Company, threatened<br \/>\nagainst the Company or any properties or rights of the Company, before any<br \/>\ncourt, arbitrator or administrative, governmental or regulatory authority or<br \/>\nbody, domestic or foreign, except for Claims that, individually or in the<br \/>\naggregate, would not have a Material Adverse Effect on the Company.<\/p>\n<p>        2.11 Employee Benefit Plans.<\/p>\n<p>                (a) All employee compensation, incentive, fringe or benefit<br \/>\nplans, programs, policies, commitments or other arrangements (whether or not set<br \/>\nforth in a written document and including, without limitation, all &#8220;employee<br \/>\nbenefit plans&#8221; within the meaning of Section 3(3) of the Employee Retirement<br \/>\nIncome Security Act of 1974, as amended (&#8220;ERISA&#8221;)) covering any active or former<br \/>\nemployee, director or consultant of the Company or any trade or business<br \/>\n(whether or not incorporated) which is a member of a controlled group or which<br \/>\nis under common control with the Company within the meaning of Section 414 of<br \/>\nthe Code (an &#8220;Affiliate&#8221;), or with respect to which the Company has or may in<br \/>\nthe future have liability, are listed in Section 2.11(a) of the Company Schedule<br \/>\n(the &#8220;Plans&#8221;). The Company has provided to Parent: (i) correct and complete<br \/>\ncopies of all documents embodying each Plan, and management, employment,<br \/>\nseverance, consulting, relocation, repatriation, expatriation, visa, work permit<br \/>\nor other agreement, contract or understanding between the Company and any<br \/>\nEmployee (&#8220;Employment Agreement&#8221;), including (without limitation) all amendments<br \/>\nthereto, all related trust documents, and all material written agreements and<br \/>\ncontracts relating to each such Plan; (ii) the three (3) most recent annual<br \/>\nreports (Form Series 5500 and all schedules and financial statements, if any,<br \/>\nrequired to be attached thereto), if any, required under ERISA or the Code in<br \/>\nconnection with each Plan; (iii) the most recent summary plan description<br \/>\ntogether with the summary(ies) of material modifications thereto, if any,<br \/>\nrequired under ERISA with respect to each Plan; (iv) all IRS or DOL<br \/>\ndetermination, opinion, notification and advisory letters; (v) all material<br \/>\ncorrespondence to or from any governmental agency relating to any Plan; (vi) all<br \/>\nCOBRA forms and related notices; (vii) all discrimination tests for each Plan<br \/>\nfor the most recent three (3) plan years; (viii) the most recent annual<br \/>\nactuarial valuations, if any required, prepared for each Plan; (ix) if the Plan<br \/>\nis funded, the most recent annual and periodic accounting of Plan assets; (x)<br \/>\nall material written agreements and contracts relating to each Plan, including,<br \/>\nbut not limited to, administrative service agreements, group annuity contracts<br \/>\nand group insurance contracts; (xi) all material communications to employees or<br \/>\nformer employees regarding in each case, relating to any amendments,<br \/>\nterminations, establishments, increases or decreases in benefits, acceleration<br \/>\nof payments or vesting schedules or other events which would result in any<br \/>\nmaterial liability under any Plan or proposed Plan; (xii) all policies<br \/>\npertaining to fiduciary liability insurance covering the<\/p>\n<p>                                      -12-<br \/>\n   17<\/p>\n<p>fiduciaries for each Plan; and (xiii) all registration statements, annual<br \/>\nreports (Form 11-K and all attachments thereto) and prospectuses prepared in<br \/>\nconnection with any Plan.<\/p>\n<p>                (b) The Company has performed in all material respects all<br \/>\nobligations required to be performed by it under, is not in default or violation<br \/>\nof, and has no knowledge of any default or violation by any other party to, each<br \/>\nPlan, and each Plan has been maintained and administered in all material<br \/>\nrespects in compliance with its terms and with the requirements prescribed by<br \/>\nany and all statutes, orders, rules and regulations (foreign or domestic),<br \/>\nincluding but not limited to ERISA and the Code, which are applicable to such<br \/>\nPlans. No suit, action or other litigation (excluding claims for benefits<br \/>\nincurred in the ordinary course of Plan activities) has been brought, or to the<br \/>\nknowledge of the Company is threatened, against or with respect to any such<br \/>\nPlan. There are no audits, inquiries or proceedings pending or, to the knowledge<br \/>\nof the Company, threatened by the Internal Revenue Service (the &#8220;IRS&#8221;) or<br \/>\nDepartment of Labor (the &#8220;DOL&#8221;) with respect to any Plans. All contributions,<br \/>\nreserves or premium payments required to be made or accrued as of the date<br \/>\nhereof to the Plans have been timely made or accrued. Any Plan intended to be<br \/>\nqualified under Section 401(a) of the Code and each trust intended to qualify<br \/>\nunder Section 501(a) of the Code (i) has either obtained a favorable<br \/>\ndetermination, notification, advisory and\/or opinion letter, as applicable, as<br \/>\nto its qualified status from the IRS or still has a remaining period of time<br \/>\nunder applicable Treasury Regulations or IRS pronouncements in which to apply<br \/>\nfor such letter and to make any amendments necessary to obtain a favorable<br \/>\ndetermination, and (ii) incorporates or has been amended to incorporate all<br \/>\nprovisions required to comply with the Tax Reform Act of 1986 and subsequent<br \/>\nlegislation. The Company does not have any plan or commitment to establish any<br \/>\nnew Plan, to modify any Plan (except to the extent required by law or to conform<br \/>\nany such Plan to the requirements of any applicable law, in each case as<br \/>\npreviously disclosed to Parent in writing, or as required by this Agreement), or<br \/>\nto enter into any new Plan. Each Plan can be amended, terminated or otherwise<br \/>\ndiscontinued after the Effective Time in accordance with its terms, without<br \/>\nliability to Parent, the Company or any of its Affiliates (other than ordinary<br \/>\nadministration expenses and expenses for benefits accrued but not yet paid).<\/p>\n<p>                (c) Neither the Company nor any of its Affiliates has at any<br \/>\ntime ever maintained, established, sponsored, participated in, or contributed to<br \/>\nany plan subject to Title IV of ERISA or Section 412 of the Code, and at no time<br \/>\nhas the Company contributed to or been requested to contribute to any<br \/>\n&#8220;multiemployer plan,&#8221; as such term is defined in ERISA or to any plan described<br \/>\nin Section 413(c) of the Code. Neither the Company nor any officer or director<br \/>\nof the Company is subject to any liability or penalty under Section 4975 through<br \/>\n4980B of the Code or Title I of ERISA. No &#8220;prohibited transaction,&#8221; within the<br \/>\nmeaning of Section 4975 of the Code or Sections 406 and 407 of ERISA, and not<br \/>\notherwise exempt under Section 408 of ERISA, has occurred with respect to any<br \/>\nPlan.<\/p>\n<p>                (d) Neither the Company nor any of its Affiliates has, prior to<br \/>\nthe Effective Time and in any material respect, violated any of the health<br \/>\ncontinuation requirements of the Consolidated Omnibus Budget Reconciliation Act<br \/>\nof 1985, as amended (&#8220;COBRA&#8221;), the requirements of the Family Medical Leave Act<br \/>\nof 1993, as amended, the requirements of the Women&#8217;s Health and Cancer Rights<br \/>\nAct, as amended, the requirements of the Newborns&#8217; and Mothers&#8217; Health<br \/>\nProtection Act of 1996, as amended, or any similar provisions of state law<br \/>\napplicable to employees of the Company. None of the Plans promises or provides<br \/>\nretiree medical or other retiree welfare benefits to<\/p>\n<p>                                      -13-<br \/>\n   18<\/p>\n<p>any person except as required by applicable law, and the Company has not<br \/>\nrepresented, promised or contracted (whether in oral or written form) to provide<br \/>\nsuch retiree benefits to any employee, former employee, director, consultant or<br \/>\nother person, except to the extent required by statute.<\/p>\n<p>                (e) Except as disclosed in Section 2.11(e) of the Company<br \/>\nSchedule, neither the execution and delivery of this Agreement, nor the<br \/>\nconsummation of the transactions contemplated hereby will (either alone or upon<br \/>\nthe occurrence of any additional or subsequent events) (i) constitute an event<br \/>\nunder any Plan, Employment Agreement, trust or loan that will or may result in<br \/>\nany payment (whether of severance pay or otherwise), acceleration, forgiveness<br \/>\nof indebtedness, vesting, distribution, increase in benefits or obligation to<br \/>\nfund benefits with respect to any Employee; or (ii) result in any payment or<br \/>\nbenefit which will or may be made by the Company or its Affiliates with respect<br \/>\nto any Employee will be characterized as a &#8220;parachute payment,&#8221; within the<br \/>\nmeaning of Section 280G(b)(2) of the Code.<\/p>\n<p>                (f) The Company has no employees outside the United States.<\/p>\n<p>        2.12 Labor Matters. (i) There are no material controversies pending or,<br \/>\nto the knowledge of the Company, threatened, between the Company and any of its<br \/>\nemployees; (ii) the Company is not a party to any collective bargaining<br \/>\nagreement or other labor union contract or arrangement with any labor union<br \/>\napplicable to persons employed by the Company nor does the Company know of any<br \/>\nactivities or proceedings of any labor union to organize any such employees; and<br \/>\n(iii) the Company has no knowledge of any labor disputes, strikes, slowdowns,<br \/>\nwork stoppages or lockouts, or threats thereof, by or with respect to any<br \/>\nemployees of the Company, and the Company has not experienced any labor<br \/>\ninterruptions over the past three (3) years. The Company is in compliance in all<br \/>\nmaterial respects with all applicable material foreign, federal, state and local<br \/>\nlaws, rules and regulations respecting employment, employment practices, terms<br \/>\nand conditions of employment and wages and hours.<\/p>\n<p>        2.13 Proxy Statement. None of the information supplied or to be supplied<br \/>\nby the Company for inclusion or incorporation by reference in the proxy<br \/>\nstatement to be filed with the SEC by the Company pursuant to Section 5.4<br \/>\nhereof, as the same may be amended from time to time (the &#8220;Proxy Statement&#8221;)<br \/>\nwill, at the dates mailed to the stockholders of the Company and at the time of<br \/>\nthe stockholders meeting of the Company (the &#8220;Company Stockholders&#8217; Meeting&#8221;) in<br \/>\nconnection with the transactions contemplated hereby, contain any untrue<br \/>\nstatement of a material fact or omit to state any material fact required to be<br \/>\nstated therein or necessary in order to make the statements therein, in light of<br \/>\nthe circumstances under which they are made, not misleading. The Proxy Statement<br \/>\nwill comply as to form in all material respects with the provisions of the<br \/>\nExchange Act and the rules and regulations promulgated by the SEC thereunder.<br \/>\nNotwithstanding the foregoing, the Company makes no representation or warranty<br \/>\nwith respect to any information supplied by Parent or Merger Sub that is<br \/>\ncontained in any of the foregoing documents.<\/p>\n<p>        2.14 Restrictions on Business Activities. There is no agreement,<br \/>\ncommitment, judgment, injunction, order or decree binding upon the Company or to<br \/>\nwhich the Company is a party which has or could reasonably be expected to have<br \/>\nthe effect of prohibiting or materially impairing any business practice of the<br \/>\nCompany (including but not limited to research and development, sales,<br \/>\nmanufacturing, marketing and employment) or the conduct of business by the<br \/>\nCompany as such<\/p>\n<p>                                      -14-<br \/>\n   19<\/p>\n<p>practice or business is currently conducted or presently anticipated by the<br \/>\nCompany to be conducted or pursued under any agreement between Parent and the<br \/>\nCompany.<\/p>\n<p>        2.15 Title to Property. The Company does not own any material real<br \/>\nproperty. The Company has good and defensible title to all of its material<br \/>\nproperties and assets it purports to own, free and clear of all liens, charges<br \/>\nand encumbrances except liens for taxes not yet due and payable, and such liens<br \/>\nor other imperfections of title, if any, as do not materially detract from the<br \/>\nvalue of or interfere with the present use of the property affected thereby. All<br \/>\nleases pursuant to which the Company lease from others material real or personal<br \/>\nproperty are in good standing, valid and effective in accordance with their<br \/>\nrespective terms, and there is not, under any of such leases, any existing<br \/>\nmaterial default or event of default (or any event which with notice or lapse of<br \/>\ntime, or both, would constitute a material default and in respect of which the<br \/>\nCompany has not taken adequate steps to prevent such default from occurring).<br \/>\nAll the plants, structures and equipment of the Company, except such as may be<br \/>\nunder construction, are in good operating condition and repair, in all material<br \/>\nrespects, subject to normal wear and tear.<\/p>\n<p>        2.16 Taxes.<\/p>\n<p>                (a) For the purposes of this Agreement, &#8220;Tax&#8221; or &#8220;Taxes&#8221; &#8220;means<br \/>\n(i) any and all federal, state, local and foreign taxes, including taxes based<br \/>\nupon or measured by gross receipts, income, profits, sales, use and occupation,<br \/>\nand value added, ad valorem, transfer, franchise, withholding, payroll,<br \/>\nrecapture, employment, excise and property taxes, together with all interest,<br \/>\npenalties and additions imposed with respect to such amounts, (ii) any liability<br \/>\nfor the payment of any amounts of the type described in clause (i) as a result<br \/>\nof being or ceasing to be a member of an affiliated, consolidated, combined or<br \/>\nunitary group for any period (including, without limitation, any liability under<br \/>\nTreasury Regulation Section 1.1502-6 or any comparable provision of foreign,<br \/>\nstate or local law), and (iii) any liability for the payment of any amounts of<br \/>\nthe type described in clause (i) or (ii) as a result of any express or implied<br \/>\nobligation to indemnify any other person or as a result of any obligations under<br \/>\nany agreements or arrangements with any other person with respect to such<br \/>\namounts and including any liability for taxes of a predecessor entity.<\/p>\n<p>                (b)<\/p>\n<p>                        (i) The Company has timely filed (taking into account<br \/>\nextensions) all federal, state, local and foreign returns, estimates,<br \/>\ninformation statements and reports (&#8220;Returns&#8221;) relating to Taxes required to be<br \/>\nfiled by the Company with any Tax authority, except such Returns which are not<br \/>\nmaterial to the Company. All such Returns were correct and complete in all<br \/>\nmaterial respects. The Company has paid all Taxes shown to be due on such<br \/>\nReturns.<\/p>\n<p>                        (ii) The Company as of the Effective Time will have<br \/>\nwithheld with respect to its employees all federal and state income Taxes, Taxes<br \/>\npursuant to the Federal Insurance Contribution Act and other Taxes, if any,<br \/>\nrequired to be withheld as of the Effective Time, except such Taxes which are<br \/>\nnot material to the Company, and have timely paid over to the proper<br \/>\ngovernmental authorities all amounts required to be withheld and paid over under<br \/>\nall applicable laws and will have paid all then due Taxes required to be paid<br \/>\npursuant to the Federal Unemployment Tax Act with respect to compensation paid<br \/>\nto its employees.<\/p>\n<p>                                      -15-<br \/>\n   20<\/p>\n<p>                        (iii) Except as disclosed in Section 2.16(b)(iii) of the<br \/>\nCompany Schedule, the Company has not been delinquent in the payment of any<br \/>\nmaterial Tax nor is there any material Tax deficiency outstanding, proposed or<br \/>\nassessed against the Company, nor has the Company executed any unexpired waiver<br \/>\nof any statute of limitations on or extending the period for the assessment or<br \/>\ncollection of any Tax.<\/p>\n<p>                        (iv) No audit or other examination of any Return of the<br \/>\nCompany by any Tax authority is presently in progress, nor has the Company been<br \/>\nnotified in writing of any request for such an audit or other examination.<\/p>\n<p>                        (v) No adjustment relating to any Returns filed by the<br \/>\nCompany has been proposed in writing by any Tax authority to the Company or any<br \/>\nrepresentative thereof.<\/p>\n<p>                        (vi) The Company has no liability for any material<br \/>\nunpaid Taxes which has not been accrued for or reserved on the Company balance<br \/>\nsheet dated December 31, 2000 in accordance with GAAP, whether asserted or<br \/>\nunasserted, contingent or otherwise, which is material to the Company, other<br \/>\nthan any liability for unpaid Taxes that may have accrued since December 31,<br \/>\n2000 in connection with the operation of the business of the Company in the<br \/>\nordinary course.<\/p>\n<p>                        (vii) There is no contract, agreement, plan or<br \/>\narrangement to which the Company is a party as of the date of this Agreement,<br \/>\nincluding but not limited to the provisions of this Agreement, covering any<br \/>\nemployee or former employee of the Company that, individually or collectively,<br \/>\nwould reasonably be expected to give rise to the payment of any amount that<br \/>\nwould not be deductible pursuant to Sections 280G, 404 or 162(m) of the Code.<br \/>\nThere is no contract, agreement, plan or arrangement to which the Company is a<br \/>\nparty or by which it is bound to compensate any individual for excise taxes paid<br \/>\npursuant to Section 4999 of the Code.<\/p>\n<p>                        (viii) The Company has not filed any consent agreement<br \/>\nunder Section 341(f) of the Code or agreed to have Section 341(f)(2) of the Code<br \/>\napply to any disposition of a subsection (f) asset (as defined in Section<br \/>\n341(f)(4) of the Code) owned by the Company.<\/p>\n<p>                        (ix) The Company is not party to and does not have any<br \/>\nobligation under any tax-sharing, tax indemnity or tax allocation agreement or<br \/>\narrangement.<\/p>\n<p>                        (x) None of the Company&#8217;s assets are tax exempt use<br \/>\nproperty within the meaning of Section 168(h) of the Code.<\/p>\n<p>                        (xi) The Company has not constituted either a<br \/>\n&#8220;distributing corporation&#8221; or a &#8220;controlled corporation&#8221; in a distribution of<br \/>\nstock qualifying for tax-free treatment under Section 355 of the Code (i) in the<br \/>\ntwo years prior to the date of this Agreement or (ii) in a distribution which<br \/>\ncould otherwise constitute part of a &#8220;plan&#8221; or &#8220;series of related transactions&#8221;<br \/>\n(within the meaning of Section 355(e) of the Code) in conjunction with the<br \/>\nMerger.<\/p>\n<p>                        (xii) Except as disclosed in Section 2.16(b)(xii) of the<br \/>\nCompany Schedule, the Company has not granted any power of attorney with respect<br \/>\nto Taxes.<\/p>\n<p>                                      -16-<br \/>\n   21<\/p>\n<p>                        (xiii) The Company is not, and has not been at any time,<br \/>\na &#8220;United States real property holding corporation&#8221; within the meaning of<br \/>\nsection 897(c) of the Code.<\/p>\n<p>        2.17 Environmental Matters. The Company (i) has obtained all applicable<br \/>\npermits, licenses and other authorizations that are required under Environmental<br \/>\nLaws the absence of which would have a Material Adverse Effect on the Company;<br \/>\n(ii) is in compliance in all material respects with all material terms and<br \/>\nconditions of such required permits, licenses and authorizations, and also is in<br \/>\ncompliance in all material respects with all other material limitations,<br \/>\nrestrictions, conditions, standards, prohibitions, requirements, obligations,<br \/>\nschedules and timetables contained in such laws or contained in any regulation,<br \/>\ncode, plan, order, decree, judgment, notice or demand letter issued, entered,<br \/>\npromulgated or approved thereunder; and (iii) has no knowledge of and has not<br \/>\nreceived any written notice of any event, condition, circumstance, activity,<br \/>\npractice, incident, action or plan that is reasonably foreseeably likely to<br \/>\ninterfere with or prevent continued compliance with any Environmental Law or<br \/>\nthat would give rise to any common law or statutory liability pursuant to any<br \/>\nEnvironmental Law, except to the extent such non-compliance, liability or<br \/>\nEnvironmental Claim could not reasonably be expected to have a Material Adverse<br \/>\nEffect on the Company. To the Company&#8217;s knowledge, no Hazardous Materials are<br \/>\npresent in, on or under any real properties owned, leased or used at any time<br \/>\n(including both land and improvements thereon) by the Company, in such manner as<br \/>\nwould give rise to any liability or corrective or remedial obligation under any<br \/>\nEnvironmental Laws. &#8220;Environmental Claim&#8221; means any written notice, claim, act,<br \/>\ncause of action or investigation by any person alleging potential liability<br \/>\n(including potential liability for investigatory costs, cleanup costs,<br \/>\ngovernmental response costs, natural resources damages, property damages,<br \/>\npersonal injuries or penalties) arising out of, based on or resulting from (i)<br \/>\nthe presence, or release into the environment, of any Hazardous Materials or<br \/>\n(ii) any violation, or alleged violation, of any Environmental Laws.<br \/>\n&#8220;Environmental Laws&#8221; means all Federal, state, local and foreign laws and<br \/>\nregulations in effect on the date hereof relating to pollution of the<br \/>\nenvironment (including ambient air, surface water, ground water, land surface or<br \/>\nsubsurface strata) or the protection of human health and worker safety,<br \/>\nincluding, without limitation, laws and regulations relating to emissions,<br \/>\ndischarges, releases or threatened releases of Hazardous Materials, or otherwise<br \/>\nrelating to the manufacture, processing, distribution, use, treatment, storage,<br \/>\ndisposal, transport or handling of Hazardous Materials. &#8220;Hazardous Materials&#8221;<br \/>\nmeans chemicals, pollutants, contaminants, wastes, toxic substances, radioactive<br \/>\nand biological materials, asbestos-containing materials, hazardous substances,<br \/>\npetroleum and petroleum products or any fraction thereof, excluding, however,<br \/>\nHazardous Materials contained in products typically used for office, janitorial<br \/>\nand\/or landscaping purposes properly and safely maintained in accordance with<br \/>\nEnvironmental Laws.<\/p>\n<p>        2.18 Brokers. The Company has not incurred, nor will it incur, directly<br \/>\nor indirectly, any liability for brokerage or finders&#8217; fees or agents&#8217;<br \/>\ncommissions or any similar charges in connection with this Agreement or any<br \/>\ntransaction contemplated hereby based upon arrangements made by or on behalf of<br \/>\nthe Company.<\/p>\n<p>        2.19 Intellectual Property. For the purposes of this Agreement, the<br \/>\nfollowing terms have the following definitions:<\/p>\n<p>        &#8220;Intellectual Property&#8221; shall mean: (i) all United States and foreign<br \/>\n        patents and applications therefor and all reissues, divisions, renewals,<br \/>\n        extensions, provisionals, continuations and<\/p>\n<p>                                      -17-<br \/>\n   22<\/p>\n<p>        continuations-in-part thereof (&#8220;Patents&#8221;); (ii) all inventions (whether<br \/>\n        patentable or not), invention disclosures, improvements, trade secrets,<br \/>\n        proprietary information, know how, technology, technical data and<br \/>\n        customer lists, and all documentation (or in the case of know how,<br \/>\n        proprietary documentation) relating to any of the foregoing; (iii) all<br \/>\n        copyrights, copyright registrations and applications therefor and all<br \/>\n        other rights corresponding thereto throughout the world; (iv) all<br \/>\n        industrial designs and any registrations and applications therefor<br \/>\n        throughout the world; (v) all trade names, logos, common law trademarks<br \/>\n        and service marks; trademark and service mark registrations and<br \/>\n        applications therefor and all goodwill associated therewith throughout<br \/>\n        the world; (vi) all databases and data collections and all rights<br \/>\n        therein throughout the world related to research, design and development<br \/>\n        of the Company&#8217;s Products; (vii) all computer software including all<br \/>\n        source code, object code, firmware, development tools, files, records<br \/>\n        and data, all media on which any of the foregoing is recorded, all Web<br \/>\n        addresses, sites and domain names; and (viii) any similar, corresponding<br \/>\n        or equivalent rights to any of the foregoing.<\/p>\n<p>        &#8220;Company Intellectual Property&#8221; shall mean any Intellectual Property<br \/>\n        that is owned by or exclusively licensed to the Company. Without in any<br \/>\n        way limiting the generality of the foregoing, Company Intellectual<br \/>\n        Property includes all Intellectual Property owned by or exclusively<br \/>\n        licensed to the Company related to or necessary to develop, market or<br \/>\n        otherwise exploit the Company&#8217;s products.<\/p>\n<p>        &#8220;Registered Intellectual Property&#8221; shall mean all United States,<br \/>\n        international and foreign: (i) patents and patent applications<br \/>\n        (including provisional applications); (ii) registered trademarks,<br \/>\n        applications to register trademarks, intent-to-use applications, or<br \/>\n        other registrations or applications related to trademarks; (iii)<br \/>\n        registered copyrights and applications for copyright registration; (iv)<br \/>\n        domain name registrations; and (v) any other application, certificate,<br \/>\n        filing, registration or other document issued by, filed with, or<br \/>\n        recorded by, any state, government or other public legal authority.<\/p>\n<p>        &#8220;Company Registered Intellectual Property&#8221; means all of the Registered<br \/>\n        Intellectual Property owned by, or filed in the name of, the Company.<\/p>\n<p>                (a) Section 2.19(a) of the Company Schedule is a complete and<br \/>\naccurate list of all Company Registered Intellectual Property and specifies,<br \/>\nwhere applicable, the jurisdictions in which each such item of Company<br \/>\nRegistered Intellectual Property has been issued or registered and lists any<br \/>\nproceedings or actions before any court, tribunal (including the United States<br \/>\nPatent and Trademark Office (the &#8220;PTO&#8221;) or equivalent authority anywhere in the<br \/>\nworld) related to any of the Company Registered Intellectual Property, and any<br \/>\nactions with respect thereto that should be taken within one hundred twenty<br \/>\n(120) days after the date of this Agreement.<\/p>\n<p>                (b) Section 2.19(b) of the Company Schedule is a complete and<br \/>\naccurate list (by name and version number, if applicable) of all products or<br \/>\nservice offerings of the Company (&#8220;Company Products&#8221;) that have been distributed<br \/>\nor provided in the five (5) year period preceding the date hereof or which the<br \/>\nCompany presently intends to distribute or provide in the next three (3) years,<br \/>\nincluding any products or service offerings under development.<\/p>\n<p>                                      -18-<br \/>\n   23<\/p>\n<p>                (c) No Company Intellectual Property owned by the Company, no<br \/>\nCompany Product, and to the Company&#8217;s knowledge, no Company Intellectual<br \/>\nProperty exclusively licensed by the Company, is subject to any proceeding or<br \/>\noutstanding decree, order, judgment, contract, license, agreement, or<br \/>\nstipulation restricting in any manner the use (in accordance with the Company&#8217;s<br \/>\ncurrent practices), transfer, or licensing thereof by the Company, or which may<br \/>\nadversely affect the use (in accordance with the Company&#8217;s current practices) or<br \/>\nenforceability of such Company Intellectual Property or Company Product.<\/p>\n<p>                (d) To the Company&#8217;s knowledge, each item of Company Registered<br \/>\nIntellectual Property is valid and subsisting, all necessary registration,<br \/>\nmaintenance and renewal fees currently due in connection with such Company<br \/>\nRegistered Intellectual Property have been made and all necessary documents,<br \/>\nrecordations and certificates in connection with such Company Registered<br \/>\nIntellectual Property have been filed with the relevant patent, copyright,<br \/>\ntrademark or other authorities in the United States or foreign jurisdictions, as<br \/>\nthe case may be, for the purposes of maintaining such Company Registered<br \/>\nIntellectual Property.<\/p>\n<p>                (e) The Company owns and has good and exclusive title to, or<br \/>\nexclusively licenses, each item of Company Intellectual Property free and clear<br \/>\nof any lien or encumbrance on such owned Company Intellectual Property or on any<br \/>\nlicense to such licensed Company Intellectual Property. Without limiting the<br \/>\nforegoing: (i) the Company is the exclusive owner of all trademarks and trade<br \/>\nnames used in connection with the operation or conduct of the business of the<br \/>\nCompany, including the sale, distribution or provision of any Company Products<br \/>\nby the Company; (ii) the Company owns exclusively, and has good title to, all<br \/>\ncopyrighted works that are Company Products or which the Company otherwise<br \/>\npurports to own; and (iii) to the extent that any Patents would be infringed by<br \/>\nany Company Products currently under development or currently proposed, to the<br \/>\nCompany&#8217;s knowledge the Company is the exclusive owner of such Patents.<\/p>\n<p>                (f) To the extent that any technology, hardware, software or<br \/>\nIntellectual Property has been developed or created in whole or in part by a<br \/>\nthird party specifically for the Company or to the extent any Intellectual<br \/>\nProperty is incorporated into or necessary to make, use or sell any of the<br \/>\nCompany Products, the Company owns or has the unrestricted perpetual,<br \/>\nnon-terminable (except for breach) license to use such third party&#8217;s<br \/>\nIntellectual Property in such work, material or invention to the extent required<br \/>\nfor or incident to the development, manufacture, operation or sale of the<br \/>\nCompany Products.<\/p>\n<p>                (g) Except as contemplated by any agreement between the Company<br \/>\nand Parent, the Company has not transferred ownership of, or granted any<br \/>\nexclusive license with respect to, any Intellectual Property that is Company<br \/>\nIntellectual Property, to any third party, or permitted the Company&#8217;s rights in<br \/>\nsuch Company Intellectual Property to lapse or enter the public domain.<\/p>\n<p>                (h) Section 2.19(h) of the Company Schedule lists all contracts,<br \/>\nlicenses and agreements to which the Company is a party: (i) with respect to<br \/>\nCompany Intellectual Property currently licensed or transferred to any third<br \/>\nparty; or (ii) pursuant to which a third party licenses or has transferred any<br \/>\nIntellectual Property to the Company.<\/p>\n<p>                                      -19-<br \/>\n   24<\/p>\n<p>                (i) All contracts, licenses and agreements relating to either<br \/>\n(i) Company Intellectual Property (other than end-user licenses in the ordinary<br \/>\ncourse) or (ii) Intellectual Property of a third party licensed to the Company<br \/>\nor used in the business of the Company in the manner currently contemplated, are<br \/>\nin full force and effect. The consummation of the transactions contemplated by<br \/>\nthis Agreement will neither violate nor result in the breach, modification,<br \/>\ncancellation, termination or suspension of such contracts, licenses and<br \/>\nagreements. The Company is in material compliance with, and has not materially<br \/>\nbreached any term of any such contracts, licenses and agreements and, to the<br \/>\nknowledge of the Company, all other parties to such contracts, licenses and<br \/>\nagreements are in compliance with, and have not materially breached any term of,<br \/>\nsuch contracts, licenses and agreements. Following the Closing Date, the<br \/>\nSurviving Corporation will be permitted to exercise all of the Company&#8217;s rights<br \/>\nunder such contracts, licenses and agreements to the same extent the Company<br \/>\nwould have been able to had the transactions contemplated by this Agreement not<br \/>\noccurred and without the payment of any additional amounts or consideration<br \/>\nother than ongoing fees, royalties or payments which the Company would otherwise<br \/>\nbe required to pay. Neither this Agreement nor the transactions contemplated by<br \/>\nthis Agreement will (as a result of agreements or commitments to which the<br \/>\nCompany is a party) result in (i) either Parent&#8217;s or the Merger Sub&#8217;s granting<br \/>\nto any third party any right to or with respect to any Intellectual Property<br \/>\nright owned by, or licensed to, either of them, (ii) either the Parent&#8217;s or the<br \/>\nMerger Sub&#8217;s being bound by, or subject to, any non-compete or other restriction<br \/>\non the operation or scope of their respective businesses, or (iii) either the<br \/>\nParent&#8217;s or the Merger Sub&#8217;s being obligated to pay any royalties or other<br \/>\namounts to any third party in excess of those payable by Parent or Merger Sub,<br \/>\nrespectively, prior to the Closing.<\/p>\n<p>                (j) To the Company&#8217;s knowledge, the operation of the business of<br \/>\nthe Company as such business currently is conducted, including (i) the Company&#8217;s<br \/>\ndesign, development, manufacture, distribution, reproduction, marketing or sale<br \/>\nof the products or services of the Company (including Company Products) and (ii)<br \/>\nthe Company&#8217;s use of any product, device or process, has not and does not<br \/>\ninfringe or misappropriate the Intellectual Property of any third party or<br \/>\nconstitute unfair competition or trade practices under the laws of any<br \/>\njurisdiction.<\/p>\n<p>                (k) The Company has not received notice from any third party<br \/>\nthat the operation of the business of the Company or any act, product or service<br \/>\nof the Company, infringes or misappropriates the Intellectual Property of any<br \/>\nthird party or constitutes unfair competition or trade practices under the laws<br \/>\nof any jurisdiction.<\/p>\n<p>                (l) To the knowledge of the Company, no person has infringed or<br \/>\nmisappropriated or is infringing or misappropriating any Company Intellectual<br \/>\nProperty.<\/p>\n<p>                (m) The Company has taken reasonable steps to protect the<br \/>\nCompany&#8217;s rights in the Company&#8217;s confidential information and trade secrets<br \/>\nthat it wishes to protect or any trade secrets or confidential information of<br \/>\nthird parties provided to the Company, and, without limiting the foregoing, the<br \/>\nCompany has and enforces a policy requiring each employee and consultant to<br \/>\nexecute a proprietary information\/confidentiality agreement substantially in the<br \/>\nform provided to Parent and all current and former employees and consultants of<br \/>\nthe Company have executed such an agreement.<\/p>\n<p>                                      -20-<br \/>\n   25<\/p>\n<p>        2.20 Agreements, Contracts and Commitments. As of the date hereof,<br \/>\nexcept as set forth in Section 2.20 of the Company Schedule, the Company is not<br \/>\na party to or is bound by:<\/p>\n<p>                (a) any employment or consulting agreement, contract or<br \/>\ncommitment with any officer or director of the Company, other than those that<br \/>\nare terminable by the Company on no more than thirty (30) days&#8217; notice without<br \/>\nliability or financial obligation to the Company;<\/p>\n<p>                (b) any agreement of indemnification or any guaranty other than<br \/>\nany agreement of indemnification entered into in connection with the purchase or<br \/>\nlicense for use by the Company of software products or services in the ordinary<br \/>\ncourse of business;<\/p>\n<p>                (c) any agreement, contract or commitment containing any<br \/>\ncovenant limiting in any respect the right of the Company to engage in any line<br \/>\nof business or to compete with any person or granting any exclusive distribution<br \/>\nrights;<\/p>\n<p>                (d) any agreement, contract or commitment currently in force<br \/>\nrelating to the disposition or acquisition by the Company after the date of this<br \/>\nAgreement of a material amount of assets not in the ordinary course of business<br \/>\nor pursuant to which the Company has any material ownership interest in any<br \/>\ncorporation, partnership, joint venture or other business enterprise;<\/p>\n<p>                (e) any dealer, distributor, joint marketing or development<br \/>\nagreement currently in force under which the Company has continuing material<br \/>\nobligations to jointly market any product, technology or service and which may<br \/>\nnot be canceled without penalty upon notice of ninety (90) days or less, or any<br \/>\nmaterial agreement pursuant to which the Company has continuing material<br \/>\nobligations to jointly develop any intellectual property that will not be owned,<br \/>\nin whole or in part, by the Company and which may not be canceled without<br \/>\npenalty upon notice of ninety (90) days or less;<\/p>\n<p>                (f) any agreement, contract or commitment currently in force to<br \/>\nprovide source code to any third party for any product or technology that is<br \/>\nmaterial to the Company taken as a whole;<\/p>\n<p>                (g) any agreement, contract or commitment currently in force to<br \/>\nlicense any third party to manufacture or reproduce any Company product, service<br \/>\nor technology or any agreement, contract or commitment currently in force to<br \/>\nsell or distribute any Company products, service or technology except agreements<br \/>\nwith distributors or sales representatives in the normal course of business<br \/>\ncancelable without penalty upon notice of ninety (90) days or less and<br \/>\nsubstantially in the form previously provided to Parent;<\/p>\n<p>                (h) any mortgages, indentures, guarantees, loans or credit<br \/>\nagreements, security agreements or other agreements or instruments relating to<br \/>\nthe borrowing of money or extension of credit;<\/p>\n<p>                (i) any material settlement agreement entered into within five<br \/>\n(5) years prior to the date of this Agreement; or<\/p>\n<p>                (j) any other agreement, contract or commitment under which the<br \/>\nCompany is contractually obligated to make or entitled to receive payments of<br \/>\n$100,000 or more individually.<\/p>\n<p>                                      -21-<br \/>\n   26<\/p>\n<p>        The Company, nor to the Company&#8217;s knowledge any other party to a Company<br \/>\nContract (as defined below), is not in breach, violation or default under, and<br \/>\nthe Company has not received written notice that it has breached, violated or<br \/>\ndefaulted under, any of the material terms or conditions of any of the<br \/>\nagreements, contracts or commitments to which the Company is a party or by which<br \/>\nit is bound that are required to be disclosed in the Company Schedule (any such<br \/>\nagreement, contract or commitment, a &#8220;Company Contract&#8221;) in such a manner as<br \/>\nwould permit any other party to cancel or terminate any such Company Contract,<br \/>\nor would permit any other party to seek material damages or other remedies (for<br \/>\nany or all of such breaches, violations or defaults, in the aggregate).<\/p>\n<p>        2.21 Insurance. The Company maintains insurance policies and fidelity<br \/>\nbonds covering the assets, business, equipment, properties, operations,<br \/>\nemployees, officers and directors of the Company (collectively, the &#8220;Insurance<br \/>\nPolicies&#8221;) which are of the type and in amounts customarily carried by persons<br \/>\nconducting businesses similar to those of the Company. There is no material<br \/>\nclaim by the Company pending under any of the material Insurance Policies as to<br \/>\nwhich coverage has been questioned, denied or disputed by the underwriters of<br \/>\nsuch policies or bonds.<\/p>\n<p>        2.22 Board Approval. The Board of Directors of the Company has, as of<br \/>\nthe date of this Agreement, unanimously (i) approved and declared advisable this<br \/>\nAgreement and the Related Agreements and has approved the Merger and the other<br \/>\ntransactions contemplated hereby and thereby, (ii) determined that the Merger is<br \/>\nfair to, and in the best interests of, the Company and its stockholders and<br \/>\n(iii) determined to recommend that the stockholders of the Company adopt and<br \/>\napprove this Agreement and approve the Merger.<\/p>\n<p>        2.23 Vote Required. The affirmative vote of the holders of a majority of<br \/>\nthe votes entitled to be cast with respect to the Merger by the holders of the<br \/>\nCompany Common Stock and Series B Convertible Preferred Stock (voting on an<br \/>\nas-converted to Company Common Stock basis), voting together as a single class,<br \/>\nis the only vote of the holders of any class or series of the Company&#8217;s capital<br \/>\nstock necessary to approve this Agreement and the transactions contemplated<br \/>\nhereby.<\/p>\n<p>        2.24 State Takeover Statutes. Neither Section 203 of the Delaware Law<br \/>\nnor, to the Company&#8217;s knowledge, any other state takeover statute or similar<br \/>\nstatute or regulation applies to the Merger, this Agreement, the Related<br \/>\nAgreements or the transactions contemplated hereby and thereby.<\/p>\n<p>                                   ARTICLE III<br \/>\n             REPRESENTATIONS AND WARRANTIES OF PARENT AND MERGER SUB<\/p>\n<p>        Parent and Merger Sub represent and warrant to the Company, subject to<br \/>\nsuch exceptions as are specifically disclosed in writing in the disclosure<br \/>\nschedule supplied by Parent to the Company dated as of the date hereof (the<br \/>\n&#8220;Parent Schedule&#8221;) as follows. The Parent Schedule shall be arranged in sections<br \/>\ncorresponding to the numbered and lettered paragraphs contained in this Article<br \/>\nIII and the disclosure in any section of the Parent Schedule shall qualify other<br \/>\nparagraphs in this Article III only to the extent that it is reasonably apparent<br \/>\nfrom a reading of such disclosure that it also qualifies or applies to such<br \/>\nother paragraph.<\/p>\n<p>                                      -22-<br \/>\n   27<\/p>\n<p>        3.1 Organization and Qualification; Subsidiaries. Each of Parent and its<br \/>\nsubsidiaries is a corporation duly organized, validly existing and in good<br \/>\nstanding under the laws of the jurisdiction of its incorporation and has the<br \/>\nrequisite corporate power and authority to own, lease and operate its assets and<br \/>\nproperties and to carry on its business as it is now being conducted, except<br \/>\nwhere the failure to do so would not, individually or in the aggregate, have a<br \/>\nMaterial Adverse Effect on Parent or Merger Sub. Each of Parent and its<br \/>\nsubsidiaries is in possession of all Approvals necessary to own, lease and<br \/>\noperate the properties it purports to own, operate or lease and to carry on its<br \/>\nbusiness as it is now being conducted, except where the failure to have such<br \/>\nApprovals would not, individually or in the aggregate, be material to Parent or<br \/>\nMerger Sub. Each of Parent and its subsidiaries is duly qualified or licensed as<br \/>\na foreign corporation to do business, and is in good standing, in each<br \/>\njurisdiction where the character of the properties owned, leased or operated by<br \/>\nit or the nature of its activities makes such qualification or licensing<br \/>\nnecessary, except for such failures to be so duly qualified or licensed and in<br \/>\ngood standing that would not, either individually or in the aggregate, have a<br \/>\nMaterial Adverse Effect on Parent or Merger Sub.<\/p>\n<p>        3.2 Authority Relative to this Agreement. Each of Parent and Merger Sub<br \/>\nhas all necessary corporate power and authority to execute and deliver this<br \/>\nAgreement and the applicable Related Agreements and to perform its obligations<br \/>\nhereunder and thereunder, and to consummate the transactions contemplated hereby<br \/>\nand thereby. The execution and delivery of this Agreement by Parent and Merger<br \/>\nSub and the consummation by Parent and Merger Sub of the transactions<br \/>\ncontemplated hereby and the execution and delivery of the applicable Related<br \/>\nAgreements by Parent and the consummation by Parent of the transactions<br \/>\ncontemplated thereby have been duly and validly authorized by all necessary<br \/>\ncorporate action on the part of Parent and Merger Sub, and no other corporate<br \/>\nproceedings on the part of Parent or Merger Sub are necessary to authorize this<br \/>\nAgreement and the applicable Related Agreements, or to consummate the<br \/>\ntransactions so contemplated. This Agreement and the Related Agreements have<br \/>\nbeen duly and validly executed and delivered by Parent and Merger Sub and,<br \/>\nassuming the due authorization, execution and delivery by the Company,<br \/>\nconstitute legal and binding obligations of Parent and Merger Sub, enforceable<br \/>\nagainst Parent and Merger Sub in accordance with their terms.<\/p>\n<p>        3.3 No Conflict; Required Filings and Consents.<\/p>\n<p>                (a) The execution and delivery of this Agreement and the<br \/>\napplicable Related Agreements by Parent and Merger Sub do not, and the<br \/>\nperformance of this Agreement and the applicable Related Agreements by Parent<br \/>\nand Merger Sub shall not, (i) conflict with or violate the Certificate of<br \/>\nIncorporation, Bylaws or equivalent organizational documents of Parent or any of<br \/>\nits subsidiaries, (ii) subject to compliance with the requirements set forth in<br \/>\nSection 3.3(b) below, conflict with or violate any Law applicable to Parent or<br \/>\nany of its subsidiaries or by which its or any of their respective properties<br \/>\nare bound or affected, or (iii) result in any breach of or constitute a default<br \/>\n(or an event that with notice or lapse of time or both would become a default)<br \/>\nunder, or impair Parent&#8217;s or any of its subsidiaries&#8217; rights or alter the rights<br \/>\nor obligations of any third party under, or give to others any rights of<br \/>\ntermination, amendment, acceleration or cancellation of, or result in the<br \/>\ncreation of a lien or encumbrance on any of the properties or assets of Parent<br \/>\nor any of its subsidiaries pursuant to, any material note, bond, mortgage,<br \/>\nindenture, contract, agreement, lease, license, permit, franchise or other<br \/>\ninstrument or obligation to which Parent or any of its subsidiaries is a party<br \/>\nor by which Parent or any of its subsidiaries or its or any of their respective<br \/>\nproperties are<\/p>\n<p>                                      -23-<br \/>\n   28<\/p>\n<p>bound or affected, except to the extent such conflict, violation, breach,<br \/>\ndefault, impairment or other effect would not in the case of clauses (ii) or<br \/>\n(iii), individually or in the aggregate, reasonably be expected to have a<br \/>\nMaterial Adverse Effect on Parent or Merger Sub.<\/p>\n<p>                (b) The execution and delivery of this Agreement and the<br \/>\napplicable Related Agreements by Parent and Merger Sub do not, and the<br \/>\nperformance of this Agreement and the applicable Related Agreements by Parent<br \/>\nand Merger Sub shall not, require any consent, approval, authorization or permit<br \/>\nof, or filing with or notification to, any Governmental Entity except (i) for<br \/>\napplicable requirements, if any, of the Securities Act, the Exchange Act, Blue<br \/>\nSky Laws, the pre-merger notification requirements of the HSR Act, the rules and<br \/>\nregulations of Nasdaq, and the filing and recordation of the Certificate of<br \/>\nMerger as required by Delaware Law and (ii) where the failure to obtain such<br \/>\nconsents, approvals, authorizations or permits, or to make such filings or<br \/>\nnotifications, would not have a Material Adverse Effect on the Parent&#8217;s or<br \/>\nMerger Sub&#8217;s ability to consummate the Merger or perform their obligations under<br \/>\nthis Agreement and the Related Agreements.<\/p>\n<p>        3.4 Ownership of Merger Sub; No Prior Activities. The Merger Sub is a<br \/>\ndirect, wholly-owned subsidiary of Parent and was formed solely for the purpose<br \/>\nof engaging in the transactions contemplated by this Agreement. Except for<br \/>\nobligations or liabilities incurred in connection with its incorporation or<br \/>\norganization and the transactions contemplated by this Agreement and except for<br \/>\nthis Agreement and any other agreements or arrangements contemplated by this<br \/>\nAgreement, the Merger Sub has not and will not have incurred, directly or<br \/>\nindirectly, through any subsidiary or affiliate, any obligations or liabilities<br \/>\nor engaged in any business activities of any type or kind whatsoever or entered<br \/>\ninto any agreements or arrangements with any person or entity which could<br \/>\nadversely affect the ability of Merger Sub or Parent to consummate the<br \/>\ntransactions contemplated hereby.<\/p>\n<p>                                   ARTICLE IV<br \/>\n                      CONDUCT PRIOR TO THE EFFECTIVE TIME<\/p>\n<p>        4.1 Conduct of Business by the Company. Except as expressly permitted by<br \/>\nthis Section 4.1 or required by the terms of this Agreement, and except as<br \/>\nprovided in Section 4.1 of the Company Schedule, without the prior written<br \/>\nconsent of Parent, during the period from the date of this Agreement and<br \/>\ncontinuing until the earlier of the termination of this Agreement pursuant to<br \/>\nits terms or the Effective Time, the Company shall carry on its business, in the<br \/>\nordinary course, in substantially the same manner as previously conducted and in<br \/>\nmaterial compliance with all applicable laws and regulations, pay its material<br \/>\ndebts and taxes when due subject to good faith disputes over such debts or<br \/>\ntaxes, pay or perform other material obligations when due, and use its<br \/>\ncommercially reasonable efforts consistent with past practices and policies to<br \/>\n(i) preserve intact its present business organization, (ii) keep available the<br \/>\nservices of its present officers and employees and (iii) preserve its<br \/>\nrelationships with customers, suppliers, distributors, licensors, licensees, and<br \/>\nothers with which it has business dealings. In addition, except as expressly<br \/>\npermitted or contemplated by the terms of this Agreement, and except as provided<br \/>\nin Section 4.1 of the Company Schedule, without the prior written consent of<br \/>\nParent, during the period from the date of this Agreement and continuing until<br \/>\nthe earlier of the termination of this Agreement pursuant to its terms or the<br \/>\nEffective Time, the Company shall not do any of the following:<\/p>\n<p>                                      -24-<br \/>\n   29<\/p>\n<p>                (a) Waive any stock repurchase rights, accelerate (except in<br \/>\nconnection with the termination of the Company Option Plan), amend or change the<br \/>\nperiod of exercisability of options or restricted stock, or reprice options<br \/>\ngranted under any employee, consultant, director or other stock plans or<br \/>\nauthorize cash payments in exchange for any options granted under any of such<br \/>\nplans;<\/p>\n<p>                (b) Grant any severance or termination pay to any officer or<br \/>\nemployee except pursuant to written agreements outstanding, or policies<br \/>\nexisting, on the date hereof and as previously disclosed in writing or made<br \/>\navailable to Parent, or adopt any new severance plan;<\/p>\n<p>                (c) Transfer or license to any person or entity or otherwise<br \/>\nextend, amend or modify any rights to the Company Intellectual Property, or<br \/>\nenter into grants to transfer or license to any person future patent rights;<\/p>\n<p>                (d) Declare, set aside or pay any dividends on or make any other<br \/>\ndistributions (whether in cash, stock, equity securities or property) in respect<br \/>\nof any capital stock or split, combine or reclassify any capital stock or issue<br \/>\nor authorize the issuance of any other securities in respect of, in lieu of or<br \/>\nin substitution for any capital stock;<\/p>\n<p>                (e) Purchase, redeem or otherwise acquire, directly or<br \/>\nindirectly, any shares of capital stock of the Company, except repurchases of<br \/>\nunvested shares at cost in connection with the termination of the employment<br \/>\nrelationship with any employee pursuant to stock option or purchase agreements<br \/>\nin effect on the date hereof or granted hereafter;<\/p>\n<p>                (f) Issue, deliver, sell, authorize, pledge or otherwise<br \/>\nencumber any shares of capital stock or any securities convertible into shares<br \/>\nof capital stock, or subscriptions, rights, warrants or options to acquire any<br \/>\nshares of capital stock or any securities convertible into shares of capital<br \/>\nstock, or enter into other agreements or commitments of any character obligating<br \/>\nit to issue any such shares or convertible securities, other than: (x) the<br \/>\nissuance, delivery and\/or sale of shares of Company Common Stock pursuant to the<br \/>\nexercise of Company Stock Options or Company Warrants outstanding as of the date<br \/>\nof this Agreement or granted pursuant to clause (y) hereof; and (y) the granting<br \/>\nof stock options to purchase up to seventy-five thousand (75,000) shares in the<br \/>\naggregate (and the issuance of Company Common Stock upon exercise thereof), in<br \/>\nthe ordinary course of business and consistent with past practices;<\/p>\n<p>                (g) Cause, permit or propose any amendments to the Company<br \/>\nCharter Documents;<\/p>\n<p>                (h) Acquire or agree to acquire by merging or consolidating<br \/>\nwith, or by purchasing any equity interest in or a portion of the assets of, or<br \/>\nby any other manner, any business or any corporation, partnership, association<br \/>\nor other business organization or division thereof, or otherwise acquire or<br \/>\nagree to acquire any assets (other than in the ordinary course of business) or<br \/>\nenter into any joint ventures, strategic partnerships or alliances;<\/p>\n<p>                (i) Sell, lease, license, encumber or otherwise dispose of any<br \/>\nproperties or assets except sales of inventory and the grant of end-user<br \/>\nlicenses in the ordinary course of business consistent with past practice,<br \/>\nexcept for the sale, lease or disposition (other than through licensing)<\/p>\n<p>                                      -25-<br \/>\n   30<\/p>\n<p>of property or assets which are not material, individually or in the aggregate,<br \/>\nto the business of the Company;<\/p>\n<p>                (j) Incur any indebtedness for borrowed money or guarantee any<br \/>\nsuch indebtedness of another person, issue or sell any debt securities or<br \/>\noptions, warrants, calls or other rights to acquire any debt securities of the<br \/>\nCompany, enter into any &#8220;keep well&#8221; or other agreement to maintain any financial<br \/>\nstatement condition or enter into any arrangement having the economic effect of<br \/>\nany of the foregoing other than (i) in connection with the financing of ordinary<br \/>\ncourse trade payables consistent with past practice or (ii) in a principal<br \/>\namount not to exceed $150,000 in the aggregate;<\/p>\n<p>                (k) Adopt or amend any employee benefit plan, policy or<br \/>\narrangement, any employee stock purchase or employee stock option plan, or enter<br \/>\ninto any employment contract or collective bargaining agreement (other than<br \/>\noffer letters and letter agreements entered into in the ordinary course of<br \/>\nbusiness consistent with past practice with employees who are terminable &#8220;at<br \/>\nwill&#8221;), pay any special bonus or special remuneration to any director or<br \/>\nemployee, or increase the salaries or wage rates (except for increases in the<br \/>\nordinary course of business for non-officer employees) or fringe benefits<br \/>\n(including rights to severance or indemnification) of its directors, officers,<br \/>\nemployees or consultants;<\/p>\n<p>                (l) (i) pay, discharge, settle or satisfy any claims,<br \/>\nliabilities or obligations (absolute, accrued, asserted or unasserted,<br \/>\ncontingent or otherwise) or litigation (whether or not commenced prior to the<br \/>\ndate of this Agreement), other than the payment, discharge, settlement or<br \/>\nsatisfaction, in the ordinary course of business consistent with past practice<br \/>\nor in accordance with their terms, of liabilities recognized or disclosed in the<br \/>\nmost recent consolidated financial statements (or the notes thereto) of the<br \/>\nCompany included in the Company SEC Reports or incurred since the date of such<br \/>\nfinancial statements, or (ii) waive the benefits of, agree to modify in any<br \/>\nmanner, terminate, release any person from or fail to enforce (without resorting<br \/>\nto litigation) any confidentiality or similar agreement to which the Company is<br \/>\na party or of which the Company is a beneficiary;<\/p>\n<p>                (m) Make any individual or series of related payments outside of<br \/>\nthe ordinary course of business (including payments to financial, legal,<br \/>\naccounting or other professional service advisors) in excess of $100,000 per<br \/>\nmonth (except that such limit shall be $500,000 for the first month following<br \/>\nthe execution of this Agreement and except that the $100,000 limit shall not<br \/>\napply to amounts owed to the Principal Shareholder or for legal services<br \/>\nperformed through the date of this Agreement);<\/p>\n<p>                (n) Except in the ordinary course of business consistent with<br \/>\npast practice, materially modify, amend or terminate any material contract or<br \/>\nagreement to which the Company is a party or waive, delay the exercise of,<br \/>\nrelease or assign any material rights or claims thereunder;<\/p>\n<p>                (o) Enter into or materially modify any contracts, agreements,<br \/>\nor obligations relating to the distribution, sale, license or marketing by third<br \/>\nparties of the Company&#8217;s products or products licensed by the Company;<\/p>\n<p>                                      -26-<br \/>\n   31<\/p>\n<p>                (p) Revalue any of its assets or, except as required or<br \/>\npermitted by GAAP, make any change in accounting methods, principles or<br \/>\npractices;<\/p>\n<p>                (q) Incur or enter into any agreement, contract or commitment<br \/>\noutside of the ordinary course of business requiring payments by the Company in<br \/>\nexcess of $100,000 individually;<\/p>\n<p>                (r) Make any tax election that, individually or in the<br \/>\naggregate, is reasonably likely to adversely affect in any material respect the<br \/>\ntax liability or tax attributes of the Company or settle or compromise any<br \/>\nmaterial income tax liability; provided, however, that nothing in this Section<br \/>\n4.1(r) or elsewhere in this Agreement shall prohibit the Company from selling<br \/>\nstate tax losses to the extent permitted by applicable taxing authorities.<\/p>\n<p>                (s) Amend or terminate any or all of the Related Agreements; or<\/p>\n<p>                (t) Agree in writing or otherwise to take any of the actions<br \/>\ndescribed in Section 4.1(a) through Section 4.1(s) above.<\/p>\n<p>        In the event the Company shall request Parent to consent in writing to<br \/>\nan action pursuant to this Section 4.1, Parent shall not unreasonably delay its<br \/>\ndetermination as to whether to withhold such consent.<\/p>\n<p>                                    ARTICLE V<br \/>\n                              ADDITIONAL AGREEMENTS<\/p>\n<p>        5.1 Initial Payment. Concurrently with the execution and delivery of<br \/>\nthis Agreement, and as a material inducement to the Company to enter into this<br \/>\nAgreement, Parent shall pay to the Company, by wire transfer, an amount equal to<br \/>\nFive Hundred Thousand Dollars ($500,000.00) (the &#8220;Initial Payment&#8221;). Without<br \/>\nlimiting the Company&#8217;s obligations pursuant to Section 7.3, in no event shall<br \/>\nthe Company be required to repay the Initial Payment to Parent, including<br \/>\nwithout limitation regardless of whether the Agreement is terminated and the<br \/>\nMerger is abandoned.<\/p>\n<p>        5.2 Related Agreements. Concurrently with the execution and delivery of<br \/>\nthis Agreement, and as a material inducement to Parent and Merger Sub to enter<br \/>\ninto this Agreement, (i) the Principal Shareholder is entering into a Voting<br \/>\nAgreement, in substantially the form attached as Exhibit A; (ii) the Principal<br \/>\nShareholder is entering into a Non-Competition Agreement, in substantially the<br \/>\nform attached as Exhibit B; (iii) Parent and the Company are entering into a<br \/>\nLicense Agreement, in substantially the form attached as Exhibit C; and (iv)<br \/>\nParent and the Company are entering into an Omnibus Waiver and Amendment<br \/>\nAgreement, in substantially the form attached as Exhibit D.<\/p>\n<p>        5.3 Parent Warrant. Concurrently with the execution of this Agreement,<br \/>\nand as a material inducement to Parent and Merger Sub to enter into this<br \/>\nAgreement, the Company shall issue and deliver to Parent the Parent Warrant, in<br \/>\nthe form attached as Exhibit E. In connection with the issuance of the Parent<br \/>\nWarrant, Parent hereby waives on behalf of itself and all future holders of the<br \/>\nSeries B Convertible Preferred Stock, the ASC Warrant and the Common Stock<br \/>\nWarrants and the shares issued or issuable thereunder any and all<br \/>\n&#8220;anti-dilution&#8221; provisions set forth in Section 5.D of the Certificate of<br \/>\nDesignations of Series B Convertible Preferred Stock of Medjet Inc. (the<\/p>\n<p>                                      -27-<br \/>\n   32<\/p>\n<p>&#8220;Certificate of Designations&#8221;), Sections 7.1, 7.2 and 7.3 of the Common Stock<br \/>\nWarrants and Sections 7.1, 7.2 and 7.3 of the ASC Warrant that might be<br \/>\ntriggered by the issuance of the Parent Warrant and the shares issued or<br \/>\nissuable thereunder.<\/p>\n<p>        5.4 Proxy Statement.<\/p>\n<p>                (a) As promptly as practicable after the execution of this<br \/>\nAgreement, the Company shall prepare and file with the SEC the Proxy Statement.<br \/>\nParent shall have the right to review and comment thereon, but in all cases<br \/>\nsubject to the control of the Company except with respect to information<br \/>\nrelating to the Parent or Merger Sub. Parent shall furnish all information<br \/>\nconcerning Parent as the Company may reasonably request in connection with such<br \/>\nactions and the preparation of the Proxy Statement. As promptly as practicable<br \/>\nafter the filing of the definitive Proxy Statement, the Proxy Statement shall be<br \/>\nmailed to the stockholders of the Company. The Company shall cause the Proxy<br \/>\nStatement to comply as to form and substance in all material respects with the<br \/>\napplicable requirements of (i) the Exchange Act, (ii) the Securities Act, and<br \/>\n(iii) the rules and regulations of the Nasdaq (applicable to the<br \/>\nOver-The-Counter market).<\/p>\n<p>                (b) The Proxy Statement shall solicit the approval of this<br \/>\nAgreement and the Merger, and subject to the right of the Board of Directors to<br \/>\nchange its recommendation if it determines in good faith (after consultation<br \/>\nwith outside counsel) it is required to do so by its fiduciary duties to the<br \/>\nstockholders of the Company under applicable law, shall include the<br \/>\nrecommendation of the Board of Directors of the Company to the Company&#8217;s<br \/>\nstockholders that they vote in favor of approval of this Agreement and the<br \/>\nMerger. Without limiting the generality of the foregoing, the Company&#8217;s<br \/>\nobligations pursuant to the first sentence of this Section 5.4(b) shall not be<br \/>\naffected by the commencement, public proposal, public disclosure or<br \/>\ncommunication to the Company of any Takeover Proposal (as defined in Section<br \/>\n5.7).<\/p>\n<p>                (c) Whenever any event occurs that is required to be set forth<br \/>\nin an amendment or supplement to the Proxy Statement, Parent or the Company, as<br \/>\nthe case may be, will promptly inform the other party of such occurrence and<br \/>\ncooperate in filing with the SEC or its staff or any other government officials,<br \/>\nand\/or mailing to stockholders of the Company, such amendment or supplement, at<br \/>\nthe expense of Parent. The Company shall promptly amend or supplement, at the<br \/>\nexpense of Parent, the Proxy Statement to the extent required by law to do so,<br \/>\nand Parent shall cooperate with respect to any amendment or supplement. Parent<br \/>\nshall have the right to review and comment on any amendment or supplement, but<br \/>\nin all cases subject to the control of the Company except with respect to<br \/>\ninformation relating to the Parent or Merger Sub. Each of the parties shall<br \/>\nadvise the other parties, promptly after it receives notice thereof, of any<br \/>\nrequest by the SEC for amendment of the Proxy Statement or comments thereon and<br \/>\nresponses thereto or requests by the SEC for additional information.<\/p>\n<p>        5.5 Stockholder Meeting. The Company shall call and hold the Company<br \/>\nStockholders&#8217; Meeting as promptly as practicable after the date hereof for the<br \/>\npurpose of voting upon the approval of this Agreement and the Merger pursuant to<br \/>\nthe Proxy Statement. Subject to Section 5.7(b), the Company shall use all<br \/>\ncommercially reasonable efforts to solicit from its stockholders proxies in<br \/>\nfavor of the approval of this Agreement and the Merger pursuant to the Proxy<br \/>\nStatement and shall take all other action necessary or advisable to secure the<br \/>\nvote or consent of stockholders required by<\/p>\n<p>                                      -28-<br \/>\n   33<\/p>\n<p>Delaware Law or applicable stock exchange requirements to obtain such approval.<br \/>\nThe Company shall take all other action, at the expense of Parent, necessary or<br \/>\nadvisable to promptly and expeditiously secure any vote or consent of<br \/>\nstockholders required by applicable Law and the Company&#8217;s Certificate of<br \/>\nIncorporation and Bylaws to effect the Merger. Notwithstanding the foregoing,<br \/>\nthe obligation of the Company to call, give notice of, convene and hold the<br \/>\nCompany Stockholders&#8217; Meeting in accordance with this Section 5.5 shall not be<br \/>\nlimited or otherwise affected by the disclosure, announcement or submission to<br \/>\nthe Company of any Takeover Proposal or by the withdrawal, amendment or<br \/>\nmodification of the recommendation of the Board of the Directors of the Company<br \/>\nwith respect to the Merger. The obligations set forth in this Section 5.5 shall<br \/>\nin no event require the Company&#8217;s Board of Directors to recommend the<br \/>\ntransactions contemplated by this Agreement to the Company&#8217;s stockholders under<br \/>\ncircumstances in which the Board of Directors has changed its recommendation in<br \/>\naccordance with Section 5.4(b).<\/p>\n<p>        5.6 Confidentiality; Access to Information.<\/p>\n<p>                (a) The parties acknowledge that the Company and Parent have<br \/>\npreviously executed a Mutual Nondisclosure Agreement, dated as of May 25, 2001<br \/>\n(the &#8220;Nondisclosure Agreement&#8221;), which Nondisclosure Agreement will continue in<br \/>\nfull force and effect in accordance with its terms.<\/p>\n<p>                (b) The Company will afford Parent and Parent&#8217;s accountants,<br \/>\ncounsel and employees reasonable access to its properties, books, records and<br \/>\npersonnel during the period prior to the Effective Time to obtain all<br \/>\ninformation concerning its business as Parent may reasonably request.<\/p>\n<p>        5.7 No Solicitation.<\/p>\n<p>                (a) From and after the date of this Agreement until the<br \/>\nEffective Time or termination of this Agreement pursuant to Article VII, the<br \/>\nCompany will not, nor will it authorize or permit any of its officers,<br \/>\ndirectors, affiliates or employees or any investment banker, attorney or other<br \/>\nadvisor or representative retained by it to, directly or indirectly, (i)<br \/>\nsolicit, initiate, encourage or induce the making, submission or announcement of<br \/>\nany Takeover Proposal (as defined below), (ii) participate in any discussions or<br \/>\nnegotiations regarding, or furnish to any person any information with respect<br \/>\nto, or take any other action to facilitate any inquiries or the making of any<br \/>\nproposal that constitutes or may reasonably be expected to lead to, any Takeover<br \/>\nProposal, (iii) engage in discussions with any person with respect to any<br \/>\nTakeover Proposal, (iv) approve, endorse or recommend any Takeover Proposal or<br \/>\n(v) enter into any letter of intent or similar document or any contract,<br \/>\nagreement or commitment contemplating or otherwise relating to any Acquisition<br \/>\nTransaction (as defined below). The Company will immediately cease any and all<br \/>\nexisting activities, discussions or negotiations with any parties conducted<br \/>\nheretofore with respect to any Takeover Proposal. Without limiting the<br \/>\nforegoing, it is understood that any violation of the restrictions set forth in<br \/>\nthis Section 5.7 by any officer, director or employee of the Company or any<br \/>\ninvestment banker acting on behalf of the Company, attorney or other advisor or<br \/>\nrepresentative of the Company shall be deemed to be a breach of this Section 5.7<br \/>\nby the Company. Notwithstanding the foregoing, in response to a Takeover<br \/>\nProposal that the Board of Directors of the Company determines in good faith<br \/>\n(after consultation with outside counsel) constitutes a Superior Proposal (as<br \/>\ndefined below) and<\/p>\n<p>                                      -29-<br \/>\n   34<\/p>\n<p>which Takeover Proposal was unsolicited and made after the date hereof and did<br \/>\nnot otherwise occur as a result of a breach of this Section 5.7, the Company<br \/>\nmay, subject to compliance with Section 5.7(c) and only to the extent in any<br \/>\nsuch case the Board of Directors of the Company determines in good faith (after<br \/>\nconsultation with outside counsel) that the failure to take such actions are<br \/>\nreasonably likely to constitute a breach of the Board&#8217;s fiduciary duties to the<br \/>\nstockholders of the Company under applicable law, (x) furnish information with<br \/>\nrespect to the Company to the person making such Takeover Proposal (and its<br \/>\nrepresentatives) pursuant to a customary confidentiality agreement containing<br \/>\nprovisions not less restrictive of such person than the Nondisclosure Agreement,<br \/>\nprovided that all such information has previously been provided to Parent or is<br \/>\nprovided to Parent prior to or at the time it is provided to such person and (y)<br \/>\nparticipate in discussions or negotiations with the person making such Takeover<br \/>\nProposal (and its representatives) regarding such Takeover Proposal.<\/p>\n<p>                (b) Neither the Board of Directors of the Company nor any<br \/>\ncommittee thereof shall (i) recommend, adopt or approve, or propose publicly to<br \/>\nrecommend, adopt or approve, any Takeover Proposal or Superior Proposal or (ii)<br \/>\napprove or recommend, or propose to approve or recommend, or allow the Company<br \/>\nto execute or enter into, any letter of intent, memorandum of understanding,<br \/>\nagreement in principle, merger agreement, acquisition agreement, option<br \/>\nagreement, joint venture agreement, partnership agreement or other similar<br \/>\nagreement (each, an &#8220;Acquisition Agreement&#8221;) constituting or related to any<br \/>\nTakeover Proposal (any action described in the foregoing clauses (i) or (ii) of<br \/>\nthis Section 5.7(b) being referred to as a &#8220;Company Adverse Recommendation<br \/>\nChange&#8221;). Notwithstanding the foregoing, the Board of Directors of the Company<br \/>\nmay make a Company Adverse Recommendation Change, if such Board of Directors<br \/>\ndetermines in good faith (after consultation with outside counsel) it is<br \/>\nrequired to do so by its fiduciary duties to the stockholders of the Company<br \/>\nunder applicable law; provided, however, that no Company Adverse Recommendation<br \/>\nChange may be made until after five business days following Parent&#8217;s receipt of<br \/>\nwritten notice (a &#8220;Notice of Adverse Recommendation&#8221;) from the Company advising<br \/>\nParent that the Board of Directors of the Company intends to make such a Company<br \/>\nAdverse Recommendation Change and specifying the terms and conditions of the<br \/>\napplicable Superior Proposal (it being understood and agreed that any amendment<br \/>\nto the financial terms or any other material term of such Superior Proposal<br \/>\nshall require a new Notice of Adverse Recommendation and a new five-day period).<br \/>\nFollowing receipt of a Notice of Adverse Recommendation, Parent shall have the<br \/>\nopportunity to present to the Board of Directors of the Company revised terms<br \/>\nfor the consummation of the Merger, including any proposed amendments or<br \/>\nmodifications to this Agreement in respect of such revised terms. The Board of<br \/>\nDirectors of the Company shall consider in good faith any such revised terms and<br \/>\namendments or modifications submitted to it by Parent. In determining whether to<br \/>\nmake a Company Adverse Recommendation Change in response to a Superior Proposal,<br \/>\nthe Board of Directors of the Company shall take into account Parent&#8217;s revised<br \/>\nterms and any proposed changes to the terms of this Agreement proposed by Parent<br \/>\nin response to a Notice of Adverse Recommendation or otherwise. Before making<br \/>\nany Company Adverse Recommendation Change, the Board of Directors of the Company<br \/>\nshall consider whether the revised terms offered by Parent are reasonably<br \/>\nequivalent or superior (based upon the factors set forth in the definition of<br \/>\nSuperior Proposal below) from the financial point of view of the Company&#8217;s<br \/>\nstockholders to the terms of the Superior Proposal and, if such terms are<br \/>\ndetermined by a vote of the Board of Directors to be reasonably equivalent or<br \/>\nsuperior from the financial point of view of the Company&#8217;s stockholders to<\/p>\n<p>                                      -30-<br \/>\n   35<\/p>\n<p>the terms of the Superior Proposal, the Board of Directors of the Company shall<br \/>\naccept at a meeting duly called and held, duly adopted resolutions (x) approving<br \/>\nand declaring advisable the terms of any such revised proposal by Parent and any<br \/>\ndefinitive agreement proposed in connection therewith, (y) directing that the<br \/>\nadoption of the terms of any such revised proposal by Parent and any definitive<br \/>\nagreement proposed in connection therewith be submitted to a vote at a meeting<br \/>\nof the stockholders of the Company and (z) recommending that the stockholders of<br \/>\nthe Company approve and adopt the terms of any such revised proposal by Parent<br \/>\nand any definitive agreement proposed in connection therewith. If the Company<br \/>\nhas elected to make a Company Adverse Recommendation Change following receipt of<br \/>\na Superior Proposal and complying with the procedures set forth in this Section<br \/>\n5.7(b) and after determining by a vote of the Board of Directors that any<br \/>\nrevised terms and proposed changes of Parent are not reasonably equivalent or<br \/>\nsuperior from the financial point of view of the Company&#8217;s stockholders to the<br \/>\nterms of the Superior Proposal, the Company shall deliver to Parent (i) a<br \/>\nwritten notice of termination of this Agreement pursuant to this Section 5.7(b),<br \/>\n(ii) a wire transfer of immediately available funds in the amount of the<br \/>\nTermination Fee (as defined in Section 7.3(a)), (iii) the License Agreement (if<br \/>\nrequired pursuant to Section 7.3(a)) and (iv) a written acknowledgment that the<br \/>\nCompany and the Board of Directors have complied with all of their covenants and<br \/>\nobligations pursuant to this Section 5.7(b) and that the Company is obligated to<br \/>\npay the Termination Fee and effect the License Grant (if required).<\/p>\n<p>                (c) In addition to the obligations of the Company set forth in<br \/>\nSection 5.7(a) and Section 5.7(b), the Company as promptly as practicable, and<br \/>\nin any event within 24 hours, shall advise Parent in writing of: any request for<br \/>\ninformation which the Company reasonably believes would lead to a Takeover<br \/>\nProposal; any request for information with respect to any Takeover Proposal; any<br \/>\ninquiry with respect to or which the Company reasonably should believe would<br \/>\nlead to any Takeover Proposal; the material terms and conditions of such<br \/>\nrequest, Takeover Proposal or inquiry; and the identity of the person or group<br \/>\nmaking any such request, Takeover Proposal or inquiry. The Company will keep<br \/>\nParent informed in all material respects of the status and details (including<br \/>\nmaterial amendments or proposed amendments) of any such request, Takeover<br \/>\nProposal or inquiry.<\/p>\n<p>                (d) Nothing contained in this Section 5.7 shall prohibit the<br \/>\nCompany from (i) taking and disclosing to its stockholders a position<br \/>\ncontemplated by Rule 14e-2(a) or Item 1012(a) of Regulation M-A promulgated<br \/>\nunder the Exchange Act if, in the good faith judgment of the Board of Directors<br \/>\nof the Company (after consultation with outside counsel) failure to so disclose<br \/>\nwould constitute a violation of applicable law or regulation; provided, however,<br \/>\nthat in no event as a result of this Section 5.7(d) shall the Company or its<br \/>\nBoard of Directors or any committee thereof take, or agree or resolve to take,<br \/>\nany action prohibited by Section 5.7(b).<\/p>\n<p>        For purposes of this Agreement, &#8220;Takeover Proposal&#8221; shall mean any offer<br \/>\nor proposal (other than an offer or proposal by Parent) relating to any<br \/>\nAcquisition Transaction. For the purposes of this Agreement, &#8220;Acquisition<br \/>\nTransaction&#8221; shall mean any transaction or series of related transactions other<br \/>\nthan the transactions contemplated by this Agreement involving: (A) any<br \/>\nacquisition or purchase from the Company by any person or &#8220;group&#8221; (as defined<br \/>\nunder Section 13(d) of the Exchange Act and the rules and regulations<br \/>\nthereunder) of more than a 15% interest in the total outstanding voting<br \/>\nsecurities of the Company or any tender offer or exchange offer that if<br \/>\nconsummated would result in any person or &#8220;group&#8221; (as defined under Section<br \/>\n13(d) of the Exchange<\/p>\n<p>                                      -31-<br \/>\n   36<\/p>\n<p>Act and the rules and regulations thereunder) beneficially owning 15% or more of<br \/>\nthe total outstanding voting securities of the Company or any merger,<br \/>\nconsolidation, business combination or similar transaction involving the Company<br \/>\npursuant to which the stockholders of the Company immediately preceding such<br \/>\ntransaction hold less than 85% of the equity interests in the surviving or<br \/>\nresulting entity of such transaction; (B) any sale, lease (other than in the<br \/>\nordinary course of business), exchange, transfer, license (other than in the<br \/>\nordinary course of business), acquisition or disposition of more than 15% of the<br \/>\nassets of the Company; or (C) any liquidation, dissolution, recapitalization or<br \/>\nother significant corporate reorganization of the Company.<\/p>\n<p>        For purposes of this Agreement, a &#8220;Superior Proposal&#8221; means any bona<br \/>\nfide, written Takeover Proposal made by a third party if the proposal is on<br \/>\nterms which the Board of Directors of the Company, determines in its good faith<br \/>\njudgment to be (x) superior to the Company&#8217;s stockholders from a financial point<br \/>\nof view to the Merger (taking into account all the terms and conditions of such<br \/>\nproposal and this Agreement (including any changes to the financial terms of<br \/>\nthis Agreement proposed by Parent in response to such offer or otherwise)), (y)<br \/>\nfor which financing, to the extent required, is then committed or which, in the<br \/>\ngood faith judgment of the Board of Directors of the Company, is reasonably<br \/>\ncapable of being obtained by such third party and (z) reasonably capable of<br \/>\nbeing completed, taking into account all financial, legal, regulatory and other<br \/>\naspects (other than the need to perform customary due diligence) of such<br \/>\nproposal.<\/p>\n<p>        5.8 Parent Standstill. From the date of execution of this Agreement<br \/>\nuntil one year after the termination of this Agreement under Section 7.1,<br \/>\nneither Parent nor any of its affiliates will directly or indirectly purchase,<br \/>\ncontract to purchase, purchase any option or contract to purchase, sell, offer<br \/>\nto purchase, contract to sell, make any short sale, sell any contract to<br \/>\npurchase, purchase any contract to sell, grant any option, right or warrant to<br \/>\npurchase, hedge or otherwise transfer or dispose of any share or securities of<br \/>\nthe Company, other than on the terms set forth in and pursuant to the Agreement<br \/>\nand the Related Agreements or with the prior consent of the Board of Directors<br \/>\nof the Company; provided, however, that Parent may exercise the Parent Warrant,<br \/>\nthe Common Stock Warrants and the ASC Warrant in accordance with their<br \/>\nrespective terms; and provided further, however, that Parent may convert the<br \/>\n10,400 shares of Series B Convertible Preferred Stock into Company Common Stock<br \/>\naccordance with the terms of the Certificate of Designations. Notwithstanding<br \/>\nthe foregoing, the Section 5.8 shall not apply if the Merger is terminated<br \/>\npursuant to Section 7.1(e) or Section 7.1(g).<\/p>\n<p>        5.9 Public Disclosure. Parent and the Company will consult with each<br \/>\nother and agree before issuing any press release or otherwise making any public<br \/>\nstatement with respect to the Merger, this Agreement or a Takeover Proposal and<br \/>\nwill not issue any such press release or make any such public statement prior to<br \/>\nsuch agreement, except as may be required by law or any listing agreement with a<br \/>\nnational securities exchange or with Nasdaq, in which case reasonable efforts to<br \/>\nconsult with the other party will be made prior to any such release or public<br \/>\nstatement. The parties have agreed to the text of the joint press release<br \/>\nannouncing the signing of this Agreement.<\/p>\n<p>        5.10 Reasonable Efforts; Notification.<\/p>\n<p>                (a) Upon the terms and subject to the conditions set forth in<br \/>\nthis Agreement, each of the parties agrees to use all commercially reasonable<br \/>\nefforts to take, or cause to be taken, all<\/p>\n<p>                                      -32-<br \/>\n   37<\/p>\n<p>actions, and to do, or cause to be done, and to assist and cooperate with the<br \/>\nother parties in doing, all things necessary, proper or advisable to consummate<br \/>\nand make effective, in the most expeditious manner practicable, the Merger and<br \/>\nthe other transactions contemplated by this Agreement, including using<br \/>\ncommercially reasonable efforts to accomplish the following: (i) the taking of<br \/>\nall reasonable acts necessary to cause the conditions precedent set forth in<br \/>\nArticle VI to be satisfied, (ii) the obtaining of all necessary actions or<br \/>\nnonactions, waivers, consents, approvals, orders and authorizations from<br \/>\nGovernmental Entities and the making of all necessary registrations,<br \/>\ndeclarations and filings (including registrations, declarations and filings with<br \/>\nGovernmental Entities, if any) and the taking of all commercially reasonable<br \/>\nsteps as may be necessary to avoid any suit, claim, action, investigation or<br \/>\nproceeding by any Governmental Entity, (iii) the obtaining of all necessary<br \/>\nconsents, approvals or waivers from third parties, (iv) the defending, at<br \/>\nParent&#8217;s expense, of any suits, claims, actions, investigations or proceedings,<br \/>\nwhether judicial or administrative, challenging this Agreement or the<br \/>\nconsummation of the transactions contemplated hereby, including seeking to have<br \/>\nany stay or temporary restraining order entered by any court or other<br \/>\nGovernmental Entity vacated or reversed and (v) the execution or delivery of any<br \/>\nadditional instruments necessary to consummate the transactions contemplated by,<br \/>\nand to fully carry out the purposes of, this Agreement. In connection with and<br \/>\nwithout limiting the foregoing, the Company and its Board of Directors shall, if<br \/>\nany state takeover statute or similar statute or regulation is or becomes<br \/>\napplicable to the Merger, this Agreement or any of the transactions contemplated<br \/>\nby this Agreement, use all commercially reasonable efforts to ensure that the<br \/>\nMerger and the other transactions contemplated by this Agreement may be<br \/>\nconsummated as promptly as practicable on the terms contemplated by this<br \/>\nAgreement and otherwise to minimize the effect of such statute or regulation on<br \/>\nthe Merger, this Agreement and the transactions contemplated hereby.<br \/>\nNotwithstanding anything to the contrary in this Agreement, nothing in this<br \/>\nAgreement shall be deemed to require Parent or the Company or any subsidiary or<br \/>\naffiliate thereof to agree to any divestiture by itself or any of its affiliates<br \/>\nof shares of capital stock or of any business, assets or property, or the<br \/>\nimposition of any material limitation on the ability of any of them to conduct<br \/>\ntheir business or to own or exercise control of such assets, properties and<br \/>\nstock.<\/p>\n<p>                (b) The Company shall give prompt written notice to Parent of<br \/>\nany representation or warranty made by it contained in this Agreement becoming<br \/>\nuntrue or inaccurate in any material respect, or any failure of the Company to<br \/>\ncomply with or satisfy in any respect any covenant, condition or agreement to be<br \/>\ncomplied with or satisfied by it under this Agreement; provided, however, that<br \/>\nno such notification shall affect the representations, warranties, covenants or<br \/>\nagreements of the parties or the conditions to the obligations of the parties<br \/>\nunder this Agreement.<\/p>\n<p>                (c) Parent shall give prompt written notice to the Company of<br \/>\nany representation or warranty made by it or Merger Sub contained in this<br \/>\nAgreement becoming untrue or inaccurate in any material respect, or any failure<br \/>\nof Parent or Merger Sub to comply with or satisfy in any respect any covenant,<br \/>\ncondition or agreement to be complied with or satisfied by it under this<br \/>\nAgreement; provided, however, that no such notification shall affect the<br \/>\nrepresentations, warranties, covenants or agreements of the parties or the<br \/>\nconditions to the obligations of the parties under this Agreement.<\/p>\n<p>        5.11 Third Party Consents. As soon as practicable following the date<br \/>\nhereof, Parent and the Company will each use its commercially reasonable efforts<br \/>\nto obtain any consents, waivers and approvals under any of its or its<br \/>\nsubsidiaries&#8217; respective material agreements, contracts, licenses or<\/p>\n<p>                                      -33-<br \/>\n   38<\/p>\n<p>leases required to be obtained in connection with the consummation of the<br \/>\ntransactions contemplated hereby.<\/p>\n<p>        5.12 401(k) Plan. The Company agrees to terminate its 401(k) plan<br \/>\nimmediately prior to Closing, unless the Parent, in its sole and absolute<br \/>\ndiscretion, agrees to sponsor and maintain such plan by providing the Company<br \/>\nwith written notice of such election at least three (3) business days before the<br \/>\nEffective Time. Unless the Parent provides such notice to the Company, the<br \/>\nParent shall receive from the Company evidence that the Company&#8217;s 401(k) plan<br \/>\nhas been terminated pursuant to resolution of the Company&#8217;s Board of Directors<br \/>\n(the form and substance of which resolutions shall be subject to review and<br \/>\napproval of the Parent), effective as of the day immediately preceding the<br \/>\nClosing Date.<\/p>\n<p>        5.13 Disclosure Supplements. From time to time prior to the Closing, the<br \/>\nCompany may supplement or amend the Company Schedule with respect to any matter<br \/>\narising or discovered after the date of this Agreement which, if existing or<br \/>\noccurring or discovered at or prior to the date of this Agreement, would have<br \/>\nbeen required to be set forth or described in the Company Schedule or which is<br \/>\nnecessary to complete or correct any information in the Company Schedule or in<br \/>\nany representation or warranty of the Company which has been rendered inaccurate<br \/>\nthereby. Any such supplements or amendments of which Parent receives written<br \/>\nnotice at or prior to the Closing shall not affect Parent&#8217;s termination rights,<br \/>\nbut if the Closing shall occur notwithstanding any such supplement or amendment,<br \/>\neach such supplement or amendment shall be deemed to modify the Company Schedule<br \/>\nfor all purposes of this Agreement and the Merger.<\/p>\n<p>        5.14 Insurance; Indemnification.<\/p>\n<p>                (a) Parent will pay to the Company approximately $244,800 in<br \/>\nrespect of premiums for a six-year run out of the Company&#8217;s $5 million<br \/>\ndirectors&#8217; and officers&#8217; liability insurance policy.<\/p>\n<p>                (b) After the Effective Time, Parent (i) will not take or permit<br \/>\nto be taken any action to alter or impair any exculpatory or indemnification<br \/>\nprovisions now existing in the certificate of incorporation, by-laws or<br \/>\nindemnification and employment agreements of the Company or any of its<br \/>\nsubsidiaries for the benefit of any individual who served as a director or<br \/>\nofficer of the Company or any of its subsidiaries at any time prior to the<br \/>\nEffective Time (except as may be required by applicable law), and (ii) shall<br \/>\ncause the Surviving Corporation to honor and fulfill such provisions until the<br \/>\ndate which is six years from the Effective Time (except as may be required by<br \/>\napplicable law); provided, however, in the event any claim or claims are<br \/>\nasserted within such period, all rights to indemnification in respect of such<br \/>\nclaim or claims shall continue until the final disposition thereof.<\/p>\n<p>                                   ARTICLE VI<br \/>\n                            CONDITIONS TO THE MERGER<\/p>\n<p>        6.1 Conditions to Obligations of Each Party to Effect the Merger. The<br \/>\nrespective obligations of each party to this Agreement to effect the Merger<br \/>\nshall be subject to the satisfaction (or waiver) at or prior to the Closing Date<br \/>\nof the following conditions:<\/p>\n<p>                                      -34-<br \/>\n   39<\/p>\n<p>                (a) No Order. No Governmental Entity shall have enacted, issued,<br \/>\npromulgated, enforced or entered any statute, rule, regulation, executive order,<br \/>\ndecree, injunction or other order (whether temporary, preliminary or permanent)<br \/>\nwhich is in effect and which has the effect of making the Merger illegal or<br \/>\notherwise prohibiting consummation of the Merger.<\/p>\n<p>                (b) Stockholder Approval. This Agreement shall have been<br \/>\napproved and adopted, and the Merger shall have been duly approved, by the<br \/>\nrequisite vote under applicable law and the Company Charter Documents, by the<br \/>\nstockholders of the Company.<\/p>\n<p>        6.2 Additional Conditions to Obligations of the Company. The obligation<br \/>\nof the Company to consummate and effect the Merger shall be subject to the<br \/>\nsatisfaction at or prior to the Closing Date of each of the following<br \/>\nconditions, any of which may be waived, in writing, exclusively by the Company:<\/p>\n<p>                (a) Representations and Warranties. The representations and<br \/>\nwarranties of Parent and Merger Sub contained in this Agreement (i) shall have<br \/>\nbeen true and correct as of the date of this Agreement and (ii) shall be true<br \/>\nand correct on and as of the Closing Date with the same force and effect as if<br \/>\nmade on the Closing Date, except for those representations and warranties which<br \/>\naddress matters only as of a particular date (which representations shall have<br \/>\nbeen true and correct as of such particular date) and except, in all such cases,<br \/>\nwhere the failure to be so true and correct (without regard to any materiality<br \/>\nstandards contained therein), individually or in the aggregate, have not had,<br \/>\nand are not reasonably likely to have, a Material Adverse Effect on Parent (it<br \/>\nbeing understood that for purposes of determining the accuracy of such<br \/>\nrepresentations and warranties, any update of or modification to the Parent<br \/>\nSchedule made or purported to have been made after the date of this Agreement<br \/>\nshall be disregarded). The Company shall have received a certificate with<br \/>\nrespect to the foregoing signed on behalf of Parent by a duly authorized officer<br \/>\nof Parent.<\/p>\n<p>                (b) Agreements and Covenants. Parent and Merger Sub shall have<br \/>\nperformed or complied in all material respects with all agreements and covenants<br \/>\nrequired by this Agreement to be performed or complied with by them on or prior<br \/>\nto the Closing Date, and the Company shall have received a certificate to such<br \/>\neffect signed on behalf of Parent by a duly authorized officer of Parent.<\/p>\n<p>                (c) Certificate of Secretary of Parent and Merger Sub. The<br \/>\nCompany shall have received certificates, validly executed by the Secretary of<br \/>\nParent and Merger Sub, certifying as to the valid adoption of resolutions of the<br \/>\nBoard of Directors of Parent and Merger Sub approving this Agreement and the<br \/>\napplicable Related Agreements and the consummation of the transactions<br \/>\ncontemplated hereby.<\/p>\n<p>                (d) Certificate of Good Standing. The Company shall have<br \/>\nreceived certificates of good standing of Parent and Merger Sub from the<br \/>\nSecretary of State of the State of Delaware, dated within a reasonable period<br \/>\nprior to the Closing.<\/p>\n<p>                (e) Omnibus Waiver and Amendment Agreement. Parent shall have<br \/>\nexecuted and delivered to the Company the Omnibus Waiver and Amendment<br \/>\nAgreement, in substantially the form attached as Exhibit D. The Omnibus Waiver<br \/>\nand Amendment Agreement shall be in full force and effect.<\/p>\n<p>                                      -35-<br \/>\n   40<\/p>\n<p>        6.3 Additional Conditions to the Obligations of Parent and Merger Sub.<br \/>\nThe obligations of Parent and Merger Sub to consummate and effect the Merger<br \/>\nshall be subject to the satisfaction at or prior to the Closing Date of each of<br \/>\nthe following conditions, any of which may be waived, in writing, exclusively by<br \/>\nParent:<\/p>\n<p>                (a) Representations and Warranties. The representations and<br \/>\nwarranties of the Company contained in this Agreement (i) shall have been true<br \/>\nand correct as of the date of this Agreement and (ii) shall, as updated pursuant<br \/>\nto Section 5.13, be true and correct on and as of the Closing Date with the same<br \/>\nforce and effect as if made on and as of the Closing Date, except for those<br \/>\nrepresentations and warranties which address matters only as of a particular<br \/>\ndate (which representations shall have been true and correct as of such<br \/>\nparticular date) and except, in all such cases, where the failure to be so true<br \/>\nand correct (without regard to any materiality standards contained therein),<br \/>\nindividually or in the aggregate, have not had, and are not reasonably likely to<br \/>\nhave, a Material Adverse Effect on the Company. Parent shall have received a<br \/>\ncertificate with respect to the foregoing signed on behalf of the Company by the<br \/>\nChief Executive Officer of the Company.<\/p>\n<p>                (b) Agreements and Covenants. The Company shall have performed<br \/>\nor complied in all material respects with all agreements and covenants required<br \/>\nby this Agreement to be performed or complied with by it at or prior to the<br \/>\nClosing Date, and Parent shall have received a certificate to such effect signed<br \/>\non behalf of the Company by the Chief Executive Officer of the Company.<\/p>\n<p>                (c) Continuation of Agreements. Those agreements listed on<br \/>\nSchedule 6.3(c) to this Agreement shall be unmodified in any manner from the<br \/>\ndate of this Agreement and be in full force and effect.<\/p>\n<p>                (d) Consents. The Company shall have obtained all consents,<br \/>\nwaivers and approvals required in connection with the consummation of the<br \/>\ntransactions contemplated hereby in connection with the agreements, contracts,<br \/>\nlicenses or leases set forth on Schedule 6.3(d).<\/p>\n<p>                (e) Resignation of Directors. Parent shall have received a<br \/>\nwritten resignation from each of the directors of the Company effective as of<br \/>\nthe Effective Time.<\/p>\n<p>                (f) No Material Adverse Change. There shall not have occurred<br \/>\nany event or condition of any character that has had or is reasonably likely to<br \/>\nhave a Material Adverse Effect on the Company since the date of this Agreement.<\/p>\n<p>                (g) Related Agreements. The Principal Shareholder shall have<br \/>\nexecuted and delivered to Parent the Voting Agreement, in substantially the form<br \/>\nattached as Exhibit A, and the Non-Competition Agreement, in substantially the<br \/>\nform attached as Exhibit B. The Voting Agreement and the Non-Competition<br \/>\nAgreement shall be in full force and effect.<\/p>\n<p>                (h) Termination of 401(k) Plan. To the extent required by<br \/>\nSection 5.12, Parent shall have received from the Company evidence that the<br \/>\nCompany&#8217;s 401(k) plan has been terminated pursuant to resolution of the<br \/>\nCompany&#8217;s Board of Directors (the form and substance of which shall<\/p>\n<p>                                      -36-<br \/>\n   41<\/p>\n<p>have been subject to review and approval of Parent), effective as of the day<br \/>\nimmediately preceding the Closing Date.<\/p>\n<p>                (i) Termination of Company Stock Options and Company Warrants.<br \/>\nParent shall have received from the Company evidence that the Company canceled<br \/>\nall outstanding Company Stock Options and Company Warrants in accordance with<br \/>\nthe terms of Section 1.6(c).<\/p>\n<p>                (j) Certificate of Secretary of the Company. Parent shall have<br \/>\nreceived a certificate, validly executed by the Secretary of the Company,<br \/>\ncertifying as to (i) the terms and effectiveness the articles of incorporation<br \/>\nand the bylaws of the Company, and (ii) the valid adoption of resolutions of the<br \/>\nBoard of Directors of the Company and the holders of the Company&#8217;s stockholders<br \/>\napproving this Agreement and the License Agreement and the consummation of the<br \/>\ntransactions contemplated hereby.<\/p>\n<p>                (k) Certificate of Good Standing. Parent shall have received<br \/>\ncertificates of good standing of the Company from (i) the Secretary of State of<br \/>\nthe State of Delaware; (ii) the Secretary of State of the State of New Jersey;<br \/>\nand (iii) the Franchise Tax Board of the State of New Jersey, each dated within<br \/>\na reasonable period prior to the Closing.<\/p>\n<p>                (l) Removal of Liens. The Company shall have removed all<br \/>\nmaterial Liens pursuant to the Uniform Commercial Code on the property of the<br \/>\nCompany.<\/p>\n<p>                (m) Sole Discretion. Parent shall have elected, in its sole<br \/>\ndiscretion, to consummate the Merger and shall have delivered a certificate<br \/>\nsigned by a duly authorized officer of the Parent that Parent elects to proceed<br \/>\nwith the Merger. Notwithstanding the foregoing Section 6.3(a) through Section<br \/>\n6.3(l), Parent need not consummate and effect this Agreement and the<br \/>\ntransactions contemplated hereby even if the conditions set forth in the<br \/>\nforegoing Section 6.3(a) through Section 6.3(l) are satisfied by the Company.<\/p>\n<p>                                   ARTICLE VII<br \/>\n                        TERMINATION, AMENDMENT AND WAIVER<\/p>\n<p>        7.1 Termination. This Agreement may be terminated and the Merger may be<br \/>\nabandoned at any time prior to the Effective Time, whether before or after the<br \/>\nrequisite approval of the stockholders of the Company:<\/p>\n<p>                (a) by Parent, for any reason or no reason;<\/p>\n<p>                (b) by mutual written agreement of Parent and the Company;<\/p>\n<p>                (c) by Parent or the Company, if the Merger shall not have been<br \/>\nconsummated by August 17, 2002 (the &#8220;Outside Date&#8221;) for any reason, unless the<br \/>\nparties agree to extend such date; provided, however, that the right to<br \/>\nterminate this Agreement under this Section 7.1(c) shall not be available to any<br \/>\nparty if any action or failure to act by that party has been a principal cause<br \/>\nof or resulted in the failure of the Merger to occur on or before such date and<br \/>\nsuch action or failure to act constitutes a material breach of any agreement or<br \/>\ncovenant of such party pursuant to this Agreement (a &#8220;Preventing Act&#8221;); and<br \/>\nprovided further, however, Parent will not be able to prevent the Company<\/p>\n<p>                                      -37-<br \/>\n   42<\/p>\n<p>from terminating this Agreement pursuant to this Section 7.1(c) based on a<br \/>\nPreventing Act by the Company without waiving the condition to closing set forth<br \/>\nin Section 6.3(m) and waiving its right to terminate this Agreement based upon<br \/>\nSection 7.1(a);<\/p>\n<p>                (d) by Parent or the Company, if a Governmental Entity shall<br \/>\nhave issued an order, decree or ruling or taken any other action, in any case<br \/>\nhaving the effect of permanently restraining, enjoining or otherwise prohibiting<br \/>\nthe Merger, which order, decree, ruling or other action is final and<br \/>\nnonappealable;<\/p>\n<p>                (e) by Parent, if (i) the Board of Directors of Company, whether<br \/>\nor not permitted pursuant to the terms hereof, withdraws, modifies or changes<br \/>\nits recommendation of this Agreement or the Merger in a manner adverse to<br \/>\nParent, (ii) the Board of Directors of Company, whether or not permitted<br \/>\npursuant to the terms hereof, shall have made a Company Adverse Recommendation<br \/>\nChange, (iii) the Company fails to comply with Section 5.7 in all material<br \/>\nrespects, (iv) a Takeover Proposal shall have been announced or otherwise become<br \/>\npublicly known and the Board of Directors of Company shall have, within ten<br \/>\nbusiness days thereafter (A) failed to recommend against acceptance of such by<br \/>\nits stockholders (including by taking no position, or indicating its inability<br \/>\nto take a position, with respect to the acceptance by its stockholders of a<br \/>\nTakeover Proposal involving a tender offer or exchange offer) or (B) failed to<br \/>\nreconfirm its approval and recommendation of this Agreement and the transactions<br \/>\ncontemplated hereby, or (v) the Board of Directors of Company resolves to take<br \/>\nany of the actions described above;<\/p>\n<p>                (f) by Parent or the Company at any time after the Company<br \/>\nStockholders&#8217; Meeting in the event that the Company&#8217;s stockholders do not<br \/>\napprove this Agreement and the Merger contemplated herein by the requisite vote<br \/>\nunder applicable law and the Company Charter Documents; provided, however, that<br \/>\nthe right to terminate this Agreement pursuant to this Section 7.1(f) shall not<br \/>\nbe available to the Company if Parent submits a notice in writing to the<br \/>\nCompany, within ten (10) days after the Company Stockholders&#8217; Meeting (or within<br \/>\nten (10) days of any other meeting of the Company&#8217;s stockholders thereafter<br \/>\nconvened to vote on this Agreement and the Merger), stating that it intends to<br \/>\nre-solicit a stockholder vote on this Agreement and the Merger; and provided<br \/>\nfurther, however, that Parent&#8217;s right to re-solicit such a stockholder vote<br \/>\nshall not be available to Parent after the Company&#8217;s stockholders twice vote not<br \/>\nto approve this Agreement and the Merger;<\/p>\n<p>                (g) by the Company, in accordance with Section 5.7(b); provided,<br \/>\nhowever, in order for the termination of this Agreement pursuant to this Section<br \/>\n7.1(g) to be deemed effective, the Company shall have complied in all material<br \/>\nrespects with all provisions contained in Section 5.7, including the notice<br \/>\nprovisions therein, and with applicable requirements of Section 7.3, including<br \/>\nthe payment of the Termination Fee and the effectiveness of the License Grant<br \/>\n(if applicable);<\/p>\n<p>                (h) by the Company, upon a breach of any representation,<br \/>\nwarranty, covenant or agreement on the part of Parent or Merger Sub set forth in<br \/>\nthis Agreement, or if any representation or warranty of Parent or Merger Sub<br \/>\nshall have become untrue, in either case such that the conditions set forth in<br \/>\nSection 6.2(a) or Section 6.2(b) would not be satisfied as of the time of such<br \/>\nbreach or as of the time such representation or warranty shall have become<br \/>\nuntrue, provided, however, that if such<\/p>\n<p>                                      -38-<br \/>\n   43<\/p>\n<p>inaccuracy in Parent&#8217;s representations and warranties or breach by Parent is<br \/>\ncurable by Parent, then the Company may not terminate this Agreement under this<br \/>\nSection 7.1(h) for thirty (30) days after delivery of written notice from the<br \/>\nCompany to Parent of such breach, provided Parent continues to exercise best<br \/>\nefforts to cure such breach (it being understood that the Company may not<br \/>\nterminate this Agreement pursuant to this Section 7.1(h) if such breach by<br \/>\nParent is cured during such thirty (30)-day period); or<\/p>\n<p>                (i) by Parent, upon a breach of any representation, warranty,<br \/>\ncovenant or agreement on the part of the Company set forth in this Agreement, or<br \/>\nif any representation or warranty of the Company shall have become untrue, in<br \/>\neither case such that the conditions set forth in Section 6.3(a) or Section<br \/>\n6.3(b) would not be satisfied as of the time of such breach or as of the time<br \/>\nsuch representation or warranty shall have become untrue, provided, however,<br \/>\nthat if such inaccuracy in the Company&#8217;s representations and warranties or<br \/>\nbreach by the Company is curable by the Company, then Parent may not terminate<br \/>\nthis Agreement under this Section 7.1(i) for thirty (30) days after delivery of<br \/>\nwritten notice from Parent to the Company of such breach, provided the Company<br \/>\ncontinues to exercise best efforts to cure such breach (it being understood that<br \/>\nParent may not terminate this Agreement pursuant to this Section 7.1(i) if such<br \/>\nbreach by the Company is cured during such thirty (30)-day period).<\/p>\n<p>        7.2 Notice of Termination. Any termination of this Agreement under<br \/>\nSection 7.1 above will be effective immediately upon the delivery of written<br \/>\nnotice of the terminating party to the other parties (or such later time as may<br \/>\nbe required by Section 7.1).<\/p>\n<p>        7.3 Effect of Termination.<\/p>\n<p>                (a) The Company shall (x) pay Parent a fee of $500,000 (the<br \/>\n&#8220;Termination Fee&#8221;), which amount shall be payable by wire transfer of same day<br \/>\nfunds to a bank account designated by Parent, and (y) subject to the proviso set<br \/>\nforth below, grant to Parent a non-exclusive license pursuant to the License<br \/>\nAgreement, in substantially the form attached hereto as Exhibit C (the &#8220;License<br \/>\nGrant&#8221;) (provided, however, that the License Grant shall not come into force and<br \/>\neffect if, prior to the termination of the Merger Agreement, the restrictions on<br \/>\ntransferability of, or the restrictive legends on, the shares of Company Common<br \/>\nStock owned by the Principal Shareholder (the &#8220;Shares&#8221;), are lifted or removed,<br \/>\nas the case may be, by the California Department of Corporations sufficient to<br \/>\nallow the transfer of interests in the Shares to Parent pursuant to the<br \/>\ntransactions contemplated by this Agreement and pursuant to the Voting<br \/>\nAgreement), in the event that:<\/p>\n<p>                        (i) (A) any Person shall have made a Takeover Proposal<br \/>\nto the Company or to its stockholders or publicly announces any Takeover<br \/>\nProposal relating to the Company after the date hereof and such Takeover<br \/>\nProposal shall not have been withdrawn and thereafter this Agreement is<br \/>\nterminated by either party pursuant to Section 7.1(f), and (B) within one year<br \/>\nafter the termination of this Agreement any Acquisition Transaction involving<br \/>\nthe Company shall have been consummated or any Acquisition Agreement with<br \/>\nrespect to an Acquisition Transaction involving the Company shall have been<br \/>\nentered into,<\/p>\n<p>                        (ii) this Agreement is terminated by Parent pursuant to<br \/>\nSection 7.1(e) or<\/p>\n<p>                                      -39-<br \/>\n   44<\/p>\n<p>                        (iii) this Agreement is terminated by the Company<br \/>\npursuant to Section 7.1(g).<\/p>\n<p>                (b) The Termination Fee shall be paid and the License Grant (if<br \/>\napplicable) shall be effected no later than (A) the date an Acquisition<br \/>\nAgreement is entered into with respect to an Acquisition Transaction involving<br \/>\nthe Company, or if no such agreement is entered into, upon the date of<br \/>\nconsummation of an Acquisition Transaction involving the Company, in the case of<br \/>\na termination described in Section 7.3(a)(i), or (B) two days after such<br \/>\ntermination, in the case of a termination described in Section 7.3(a)(ii) or (C)<br \/>\nconcurrently with such termination, in the case of a termination described in<br \/>\nSection 7.3(a)(iii).<\/p>\n<p>                (c) Parent shall pay to Company a fee of: (A) $200,000, if such<br \/>\ntermination occurs within nine months after the date of this Agreement; (B)<br \/>\n$300,000, if such termination occurs between nine and ten months after the date<br \/>\nof this Agreement; (C) $400,000, if such termination occurs between ten and<br \/>\neleven months after the date of this Agreement; and (D) $500,000, if such<br \/>\ntermination occurs after the end of the eleventh month after the date of this<br \/>\nAgreement (which fee shall be payable immediately by wire transfer of same day<br \/>\nfunds to a bank account designated by the Company), in the event that:<\/p>\n<p>                        (i) Parent terminates this Agreement pursuant to Section<br \/>\n7.1(a);<\/p>\n<p>                        (ii) Parent terminates this Agreement pursuant to<br \/>\nSection 7.1(c); or<\/p>\n<p>                        (iii) the Company terminates this Agreement pursuant to<br \/>\nSection 7.1(c); provided, however, that Parent shall not be obligated to make<br \/>\npayment of such fee pursuant to this clause (iii) if Parent shall have given<br \/>\nnotice of termination pursuant to Section 7.1(i) prior to the Company&#8217;s<br \/>\ntermination pursuant to Section 7.1(c) and the cure period in Section 7.1(i), if<br \/>\na cure period is applicable, shall not have expired, unless the breach or<br \/>\ninaccuracy in respect of which such notice was given has been cured.<\/p>\n<p>                (d) Each of the parties acknowledges that the agreements<br \/>\ncontained in this Section 7.3 are an integral part of the transactions<br \/>\ncontemplated in this Agreement and that, without these agreements, the parties<br \/>\nwould not enter into this Agreement; accordingly, if (i) the Company fails to<br \/>\npromptly pay the Termination Fee or effect the License Grant (if applicable),<br \/>\nand in order to obtain such Termination Fee or License Grant, the Parent<br \/>\ncommences a suit which results in a judgment for the Termination Fee and\/or the<br \/>\nLicense Grant set forth in this Section 7.3, the Company shall pay to Parent its<br \/>\ncosts and expenses (including reasonable attorneys&#8217; fees) in connection with<br \/>\nsuch suit or (ii) Parent fails to promptly pay the amount provided for in<br \/>\nSection 7.3(c), and in order to obtain such amount, the Company commences a suit<br \/>\nwhich results in a judgment for such amount, Parent shall pay to the Company its<br \/>\ncosts and expenses (including reasonable attorneys&#8217; fees) in connection with<br \/>\nsuch suit.<\/p>\n<p>                (e) In the event of the termination of this Agreement as<br \/>\nprovided in Section 7.1, this Agreement shall be of no further force or effect,<br \/>\nand the parties shall have no further liability or obligation hereunder, except<br \/>\n(i) as set forth in this Section 7.3, Section 5.1, Section 5.3, Section 5.6(a),<br \/>\nSection 7.4 and Article VIII, each of which shall survive the termination of<br \/>\nthis<\/p>\n<p>                                      -40-<br \/>\n   45<\/p>\n<p>Agreement, and (ii) nothing in this Agreement shall relieve any party from<br \/>\nliability for fraud in connection with, or any willful breach of, this<br \/>\nAgreement.<\/p>\n<p>                (f) Effective upon the termination of this Agreement as provided<br \/>\nin any subsection of Section 7.1 except Section 7.1(e) and Section 7.1(g),<br \/>\nParent hereby:<\/p>\n<p>                        (i) waives Section 3.B(iv) of the Certificate of<br \/>\nDesignations to the extent that such provision would hinder the Company from<br \/>\nraising equity financing;<\/p>\n<p>                        (ii) waives any &#8220;demand&#8221; registration rights as set<br \/>\nforth in Section 2.1 of the Registration Rights Agreement, dated as of December<br \/>\n3, 1999, by and among the Company, ASC and the Stockholders listed therein, as<br \/>\namended by the First Amendment to the Registration Rights Agreement, dated as of<br \/>\nAugust 17, 2001, by and among the Company, ASC, the Stockholders and Parent and<br \/>\nthe Second Amendment to the Registration Rights Agreement, dated as of August<br \/>\n17, 2001, by and between the Company and Parent (collectively, the &#8220;Rights<br \/>\nAgreement&#8221;), for a period of one year after such termination; and<\/p>\n<p>                        (iii) amends Section 7 of the Common Stock Warrant and<br \/>\nSection 7 of the ASC Warrant to provide that upon an equity financing in which<br \/>\nthe price per share (as determined in accordance with the applicable provisions<br \/>\nof the Common Stock Warrants and the ASC Warrant) is less than the &#8220;Purchase<br \/>\nPrice per share&#8221; (as defined in the Common Stock Warrants and the ASC Warrant),<br \/>\nthe &#8220;anti-dilution&#8221; rights contained in the Common Stock Warrants and the ASC<br \/>\nWarrant will be limited to decreasing the &#8220;Purchase Price per share&#8221; of the<br \/>\nCommon Stock Warrants and the ASC Warrant to equal the lowest price per share at<br \/>\nwhich the additional equity financing is raised, but will not result in an<br \/>\nincrease in the number of shares of Company Common Stock that can be purchased<br \/>\npursuant to the Common Stock Warrants and the ASC Warrant;<\/p>\n<p>        such waiver and amendment to be effected pursuant to the Omnibus Waiver<br \/>\nand Amendment Agreement, in substantially the form attached as Exhibit D.<\/p>\n<p>        7.4 Fees and Expenses. Except as set forth in this Section 7.4, all fees<br \/>\nand expenses incurred in connection with this Agreement and the transactions<br \/>\ncontemplated hereby shall be paid by the party incurring such expenses whether<br \/>\nor not the Merger is consummated; provided, however, that Parent shall bear all<br \/>\nfees and expenses (including without limitation the Company&#8217;s reasonable<br \/>\nattorneys&#8217; and accountants&#8217; fees and expenses) incurred in relation to the<br \/>\nprinting and filing of the Proxy Statement (including any preliminary materials<br \/>\nrelated thereto) and any amendments or supplements thereto.<\/p>\n<p>        7.5 Amendment. Subject to applicable law, this Agreement may be amended<br \/>\nby the parties at any time by execution of an instrument in writing signed on<br \/>\nbehalf of each of Parent, Merger Sub and the Company.<\/p>\n<p>        7.6 Extension; Waiver. At any time prior to the Effective Time, any<br \/>\nparty may, to the extent legally allowed, (i) extend the time for the<br \/>\nperformance of any of the obligations or other acts of the other parties, (ii)<br \/>\nwaive any inaccuracies in the representations and warranties made to such party<br \/>\ncontained in this Agreement or in any document delivered pursuant hereto and<br \/>\n(iii) waive<\/p>\n<p>                                      -41-<br \/>\n   46<\/p>\n<p>compliance with any of the agreements or conditions for the benefit of such<br \/>\nparty contained herein. Any agreement on the part of a party to any such<br \/>\nextension or waiver shall be valid only if set forth in an instrument in writing<br \/>\nsigned on behalf of such party. Delay in exercising any right under this<br \/>\nAgreement shall not constitute a waiver of such right.<\/p>\n<p>                                  ARTICLE VIII<br \/>\n                               GENERAL PROVISIONS<\/p>\n<p>        8.1 Survival of Representations and Warranties. The representations and<br \/>\nwarranties of the Company, Parent and Merger Sub contained in this Agreement<br \/>\nshall terminate at the earlier of (a) the date of termination pursuant to<br \/>\nSection 7.1 or (b) the Effective Time, and only the covenants that by their<br \/>\nterms survive such date shall survive.<\/p>\n<p>        8.2 Notices. All notices and other communications hereunder shall be in<br \/>\nwriting and shall be deemed given if delivered personally or by commercial<br \/>\ndelivery service, or sent via telecopy (receipt confirmed) to the parties at the<br \/>\nfollowing addresses or telecopy numbers (or at such other address or telecopy<br \/>\nnumbers for a party as shall be specified by like notice):<\/p>\n<p>               (a)    if to Parent or Merger Sub, to:<br \/>\n                      VISX, Incorporated<br \/>\n                      3400 Central Expressway<br \/>\n                      Santa Clara, California 95051-0703<br \/>\n                      Attention: Chief Financial Officer<br \/>\n                      Telephone No.:  (408) 773-7003<br \/>\n                      Facsimile No.:  (408) 773-7201<\/p>\n<p>                      with a copy to:<\/p>\n<p>                      Wilson Sonsini Goodrich &amp; Rosati<br \/>\n                      Professional Corporation<br \/>\n                      650 Page Mill Road<br \/>\n                      Palo Alto, California 94304<br \/>\n                      Attention:  John V. Roos, Esq.<br \/>\n                      Telephone No.: (650) 493-9300<br \/>\n                      Facsimile No.: (650) 493-6811<\/p>\n<p>               (b)    if to the Company, to:<\/p>\n<p>                      Medjet Inc.<br \/>\n                      1090 King George Post Road, Suite 301<br \/>\n                      Edison, NJ 08837<br \/>\n                      Attention:  Eugene I. Gordon<br \/>\n                      Telephone No.: (732) 738-3990<br \/>\n                      Facsimile No.:  (732) 738-3984<\/p>\n<p>                      with a copy to:<\/p>\n<p>                                      -42-<br \/>\n   47<\/p>\n<p>                      Kelley Drye &amp; Warren LLP<br \/>\n                      101 Park Avenue<br \/>\n                      New York, NY 10178-0002<br \/>\n                      Attention:  Jane E. Jablons, Esq.<br \/>\n                      Telephone No.:  (212) 808-7800<br \/>\n                      Facsimile No.:  (212) 808-7897<\/p>\n<p>        8.3 Interpretation; Definitions.<\/p>\n<p>                (a) When a reference is made in this Agreement to Exhibits, such<br \/>\nreference shall be to an Exhibit to this Agreement unless otherwise indicated.<br \/>\nWhen a reference is made in this Agreement to Sections, such reference shall be<br \/>\nto a Section of this Agreement. Unless otherwise indicated the words &#8220;include,&#8221;<br \/>\n&#8220;includes&#8221; and &#8220;including&#8221; when used in this Agreement shall be deemed in each<br \/>\ncase to be followed by the words &#8220;without limitation.&#8221; The table of contents and<br \/>\nheadings contained in this Agreement are for reference purposes only and shall<br \/>\nnot affect in any way the meaning or interpretation of this Agreement. When<br \/>\nreference is made in this Agreement to &#8220;the business of&#8221; an entity, such<br \/>\nreference shall be deemed to include the business of all direct and indirect<br \/>\nsubsidiaries of such entity. Reference to the subsidiaries of an entity shall be<br \/>\ndeemed to include all direct and indirect subsidiaries of such entity.<\/p>\n<p>                (b) For purposes of this Agreement:<\/p>\n<p>                        (i) the term &#8220;knowledge&#8221; means with respect to a party<br \/>\nhereto, with respect to any matter in question, the actual knowledge of the<br \/>\nexecutive officers of such party after reasonable inquiry;<\/p>\n<p>                        (ii) the term &#8220;Material Adverse Effect&#8221; when used in<br \/>\nconnection with an entity means any change, event, violation, inaccuracy,<br \/>\ncircumstance or effect that is, or could reasonably be expected to be,<br \/>\nmaterially adverse to the business, assets, liabilities, financial or other<br \/>\ncondition, or results of operations of such entity and its subsidiaries taken as<br \/>\na whole;<\/p>\n<p>                        (iii) the term &#8220;person&#8221; shall mean any individual,<br \/>\ncorporation (including any non-profit corporation), general partnership, limited<br \/>\npartnership, limited liability partnership, joint venture, estate, trust,<br \/>\ncompany (including any limited liability company or joint stock company), firm<br \/>\nor other enterprise, association, organization, entity or Governmental Entity.<\/p>\n<p>        8.4 Counterparts. This Agreement may be executed in one or more<br \/>\ncounterparts, all of which shall be considered one and the same agreement and<br \/>\nshall become effective when one or more counterparts have been signed by each of<br \/>\nthe parties and delivered to the other party, it being understood that all<br \/>\nparties need not sign the same counterpart.<\/p>\n<p>        8.5 Entire Agreement; Third Party Beneficiaries. This Agreement and the<br \/>\ndocuments and instruments and other agreements among the parties as contemplated<br \/>\nby or referred to in this Agreement, including the Related Agreements, the<br \/>\nParent Warrant, the Company Schedule and the Parent Schedule: (a) constitute the<br \/>\nentire agreement among the parties with respect to the subject<\/p>\n<p>                                      -43-<br \/>\n   48<\/p>\n<p>matter hereof and supersede all prior agreements and understandings, both<br \/>\nwritten and oral, among the parties with respect to the subject matter hereof,<br \/>\nit being understood that the Nondisclosure Agreement shall continue in full<br \/>\nforce and effect until the Closing and shall survive any termination of this<br \/>\nAgreement; and (b) are not intended to confer upon any other person any rights<br \/>\nor remedies hereunder (except as provided in Section 5.14 with respect to the<br \/>\ndirectors and officers of the Company).<\/p>\n<p>        8.6 Severability. In the event that any provision of this Agreement, or<br \/>\nthe application thereof, becomes or is declared by a court of competent<br \/>\njurisdiction to be illegal, void or unenforceable, the remainder of this<br \/>\nAgreement will continue in full force and effect and the application of such<br \/>\nprovision to other persons or circumstances will be interpreted so as reasonably<br \/>\nto effect the intent of the parties. The parties further agree to replace such<br \/>\nvoid or unenforceable provision of this Agreement with a valid and enforceable<br \/>\nprovision that will achieve, to the extent possible, the economic, business and<br \/>\nother purposes of such void or unenforceable provision.<\/p>\n<p>        8.7 Other Remedies; Specific Performance. Except as otherwise provided<br \/>\nin this Agreement, any and all remedies expressly conferred upon a party will be<br \/>\ndeemed cumulative with and not exclusive of any other remedy conferred hereby,<br \/>\nor by law or equity upon such party, and the exercise by a party of any one<br \/>\nremedy will not preclude the exercise of any other remedy. The parties agree<br \/>\nthat irreparable damage would occur in the event that any of the provisions of<br \/>\nthis Agreement were not performed in accordance with their specific terms or<br \/>\nwere otherwise breached. It is accordingly agreed that the parties shall be<br \/>\nentitled to seek an injunction or injunctions to prevent breaches of this<br \/>\nAgreement and to enforce specifically the terms and provisions hereof in any<br \/>\ncourt of the United States or any state having jurisdiction, this being in<br \/>\naddition to any other remedy to which they are entitled at law or in equity.<\/p>\n<p>        8.8 Governing Law. This Agreement shall be governed by and construed in<br \/>\naccordance with the laws of the State of Delaware, regardless of the laws that<br \/>\nmight otherwise govern under applicable principles of conflicts of law thereof.<\/p>\n<p>        8.9 Rules of Construction. The parties agree that they have been<br \/>\nrepresented by counsel during the negotiation and execution of this Agreement<br \/>\nand, therefore, waive the application of any law, regulation, holding or rule of<br \/>\nconstruction providing that ambiguities in an agreement or other document will<br \/>\nbe construed against the party drafting such agreement or document.<\/p>\n<p>        8.10 Assignment. No party may assign either this Agreement or any of its<br \/>\nrights, interests, or obligations hereunder without the prior written approval<br \/>\nof the other parties. Any purported assignment without the consent required<br \/>\npursuant to the preceding sentence shall be null and void. Subject to the second<br \/>\npreceding sentence, this Agreement shall be binding upon and shall inure to the<br \/>\nbenefit of the parties and their respective successors and permitted assigns.<\/p>\n<p>                [remainder of the page intentionally left blank]<\/p>\n<p>                                      -44-<br \/>\n   49<\/p>\n<p>        IN WITNESS WHEREOF, Parent, Merger Sub and the Company have caused this<br \/>\nAgreement to be signed, all as of the date first written above.<\/p>\n<p>                                       VISX, INCORPORATED<\/p>\n<p>                                       By:<br \/>\n                                          &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                            Name:    Derek A. Bertocci<br \/>\n                                            Title:   Vice President, Controller<\/p>\n<p>                                       ORION ACQUISITION CORPORATION<\/p>\n<p>                                       By:<br \/>\n                                          &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                            Name:    Derek A. Bertocci<br \/>\n                                            Title:   Vice President, Chief<br \/>\n                                                     Financial Officer<\/p>\n<p>                                       MEDJET INC.<\/p>\n<p>                                       By:<br \/>\n                                          &#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<br \/>\n                                            Name:    Eugene I. Gordon<br \/>\n                                            Title:   Chief Executive Officer<\/p>\n<p>       [SIGNATURE PAGE TO AGREEMENT AND PLAN OF MERGER AND REORGANIZATION]<\/p>\n<p>   50<\/p>\n<p>                                INDEX OF EXHIBITS<\/p>\n<table>\n<caption>\n        EXHIBIT              DESCRIPTION<br \/>\n        &#8212;&#8212;-              &#8212;&#8212;&#8212;&#8211;<br \/>\n<s>                          <c><br \/>\n        Exhibit A            Form of Voting Agreement<\/p>\n<p>        Exhibit B            Form of Non-Competition Agreement<\/p>\n<p>        Exhibit C            Form of License Agreement<\/p>\n<p>        Exhibit D            Form of Omnibus Waiver and Amendment Agreement<\/p>\n<p>        Exhibit E            Form of Parent Warrant<\/p>\n<p>        Exhibit F            Form of Certificate of Merger<\/p>\n<p>        Exhibit G            Form of Amended and Restated Certificate of<br \/>\n                             Incorporation of the Company<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>   51<\/p>\n<p>                                    EXHIBIT A<\/p>\n<p>                            FORM OF VOTING AGREEMENT<\/p>\n<p>   52<\/p>\n<p>                                    EXHIBIT B<\/p>\n<p>                        FORM OF NON-COMPETITION AGREEMENT<\/p>\n<p>   53<\/p>\n<p>                                    EXHIBIT C<\/p>\n<p>                            FORM OF LICENSE AGREEMENT<\/p>\n<p>   54<\/p>\n<p>                                    EXHIBIT D<\/p>\n<p>                 FORM OF OMNIBUS WAIVER AND AMENDMENT AGREEMENT<\/p>\n<p>   55<\/p>\n<p>                                    EXHIBIT E<\/p>\n<p>                             FORM OF PARENT WARRANT<\/p>\n<p>   56<\/p>\n<p>                                    EXHIBIT F<\/p>\n<p>                          FORM OF CERTIFICATE OF MERGER<\/p>\n<p>   57<\/p>\n<p>                                    EXHIBIT G<\/p>\n<p>            FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION<br \/>\n                                 OF THE COMPANY<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[8178,9266],"corporate_contracts_industries":[9436],"corporate_contracts_types":[9622,9626],"class_list":["post-43026","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-medjet-inc","corporate_contracts_companies-visx-inc","corporate_contracts_industries-health__instruments","corporate_contracts_types-planning","corporate_contracts_types-planning__merger"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43026","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43026"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43026"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43026"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43026"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}